Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Nuclear Medicine

  Free Subscription


Articles published in Nucl Med Commun

Retrieve available abstracts of 582 articles:
HTML format



Single Articles


    July 2021
  1. YOUNG JD, Jauregui-Osoro M, Wong WL, Cooper MS, et al
    An overview of nuclear medicine research in the UK and the landscape for clinical adoption.
    Nucl Med Commun. 2021 Jul 19. pii: 00006231-900000000-97998.
    PubMed     Abstract available


  2. NORIKANE T, Mitamura K, Yamamoto Y, Hatakeyama T, et al
    Correlation of 4'-[methyl-11C]-thiothymidine PET with Ki-67 immunohistochemistry separately in patients with newly diagnosed and recurrent gliomas.
    Nucl Med Commun. 2021 Jul 19. pii: 00006231-900000000-97996.
    PubMed     Abstract available


  3. OKUDAN B, Coskun N, Seven B, Atalay MA, et al
    Assessment of volumetric parameters derived from 68Ga-PSMA PET/CT in prostate cancer patients with biochemical recurrence: an institutional experience.
    Nucl Med Commun. 2021 Jul 19. pii: 00006231-900000000-97994.
    PubMed     Abstract available


  4. HUA J, Li L, Liu L, Liu Q, et al
    The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer.
    Nucl Med Commun. 2021 Jul 15. pii: 00006231-900000000-97999.
    PubMed     Abstract available


  5. DUONG MT, Chen YJ, Doot RK, Young AJ, et al
    Astrocyte activation imaging with 11C-acetate and amyloid PET in mild cognitive impairment due to Alzheimer pathology.
    Nucl Med Commun. 2021 Jul 5. pii: 00006231-900000000-98000.
    PubMed     Abstract available


    June 2021
  6. KAPSORITAKIS N, Stathaki M, Bourogianni O, Tsaroucha A, et al
    Clinical impact of targeted single-photon emission computed tomography/computed tomography (SPECT/CT) bone scintigraphy on the assessment of bone metastasis in cancer patients.
    Nucl Med Commun. 2021 Jun 18. pii: 00006231-900000000-98001.
    PubMed     Abstract available


  7. NGUYEN TD, Lin D, Hernandez Pampaloni M
    False positive pharmacologic myocardial perfusion SPECT study in the setting of a left bundle branch block.
    Nucl Med Commun. 2021 Jun 7. pii: 00006231-900000000-98006.
    PubMed     Abstract available


  8. IGARASHI C, Yoshii Y, Tashima H, Iwao Y, et al
    Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer.
    Nucl Med Commun. 2021 Jun 7. pii: 00006231-900000000-98005.
    PubMed     Abstract available


  9. COSKUN N, Okudan B, Uncu D, Kitapci MT, et al
    Baseline 18F-FDG PET textural features as predictors of response to chemotherapy in diffuse large B-cell lymphoma.
    Nucl Med Commun. 2021 Jun 1. pii: 00006231-900000000-98011.
    PubMed     Abstract available


  10. DEV ID, Puranik AD, Purandare NC, Gupta T, et al
    Prognostic significance of 18F-FDG PET/CT parameters in IDH-1 wild-type GBM and correlation with molecular markers.
    Nucl Med Commun. 2021 Jun 1. pii: 00006231-900000000-98010.
    PubMed     Abstract available


  11. AGRAWAL K, Swaroop S, Patro PSS, Tripathy SK, et al
    Comparison of bone SPECT/CT and MRI in detection of pain generator in ankle and foot pain: a retrospective diagnostic study.
    Nucl Med Commun. 2021 Jun 1. pii: 00006231-900000000-98009.
    PubMed     Abstract available


    May 2021
  12. ADIN ME, Uazeno H, Isufi E, Pang Y, et al
    Clinical PET/CT utilization during the COVID-19 pandemic: initial experience at Yale University.
    Nucl Med Commun. 2021 May 26. pii: 00006231-900000000-98012.
    PubMed     Abstract available


  13. SOYLUOGLU S, Korkmaz U, Ozdemir B, Ustun F, et al
    68Ga-PSMA-I&T-PET/CT interobserver and intraobserver agreement for prostate cancer: a lesion based and subregional comparison study among observers with different levels of experience.
    Nucl Med Commun. 2021 May 17. pii: 00006231-900000000-98026.
    PubMed     Abstract available


  14. DIBBLE EH, Baird GL, Fahey FH, Hyun H, et al
    PET/computed tomography in inpatients: part 1, international survey.
    Nucl Med Commun. 2021 May 17. pii: 00006231-900000000-98024.
    PubMed     Abstract available


  15. MESGUICH C, Hindie E, de Senneville BD, Tlili G, et al
    Improved 18-FDG PET/CT diagnosis of multiple myeloma diffuse disease by radiomics analysis.
    Nucl Med Commun. 2021 May 17. pii: 00006231-900000000-98020.
    PubMed     Abstract available


  16. KARYAGAR S, Guven O, Karyagar SS, Arici S, et al
    Can 68Ga-PSMA PET/CT-derived prostate-specific membrane antigen expression parameters predict prostate-specific antigen response to enzalutamide treatment?
    Nucl Med Commun. 2021 May 6. pii: 00006231-900000000-98030.
    PubMed     Abstract available


  17. LIU Y, Yao X, Wang C, Wang M, et al
    Peptide-based 68Ga-PET radiotracer for imaging CD133 expression in colorectal cancer.
    Nucl Med Commun. 2021 May 6. pii: 00006231-900000000-98029.
    PubMed     Abstract available



  18. Abstracts: British Nuclear Medicine Society Online Spring Meeting 18th-19th May 2021.
    Nucl Med Commun. 2021;42:575-581.
    PubMed    


    April 2021
  19. JIANG Y, Hou G, Huo L, Li F, et al
    18F-FDG PET/computed tomography scan in patients with suspicion of recurrent neuroendocrine carcinoma of the cervix.
    Nucl Med Commun. 2021 Apr 27. pii: 00006231-900000000-98032.
    PubMed     Abstract available


  20. KE L, Wu L, Yu J, Meng X, et al
    Feasibility of semiquantitative 18F-fluorodeoxyglucose PET/computed tomography in patients with advanced lung cancer for interim treatment evaluation of combining immunotherapy and chemotherapy.
    Nucl Med Commun. 2021 Apr 21. pii: 00006231-900000000-98033.
    PubMed     Abstract available


  21. KIM JY, Kim JY, Park SB, Kim C, et al
    A retrospective multicenter study of quantitative bone SPECT/CT to predict the surgical removal of the accessory navicular bone.
    Nucl Med Commun. 2021 Apr 16. pii: 00006231-900000000-98034.
    PubMed     Abstract available


  22. WATERSCHOOT R, D'Asseler Y, Goethals I
    Comparison of an in-house acquired brain F-18 FDG PET normal database with commercially available normal data.
    Nucl Med Commun. 2021 Apr 15. pii: 00006231-900000000-98035.
    PubMed     Abstract available


  23. RAUF MS, Khan ZA, Zahir MN, Al-Sweedan S, et al
    Comparison of 18F-labelled fluoro-2-deoxyglucose-PET with conventional computed tomography for staging and response assessment in paediatric and adult patients with nodular lymphocyte-predominant Hodgkin's lymphoma.
    Nucl Med Commun. 2021 Apr 9. pii: 00006231-900000000-98040.
    PubMed     Abstract available


  24. JALEEL J, Tripathi M, Baghel V, Arunraj ST, et al
    F-18 ML-104 tau PET imaging in mild cognitive impairment.
    Nucl Med Commun. 2021 Apr 9. pii: 00006231-900000000-98039.
    PubMed     Abstract available


  25. SIRAKRIENGKRAI K, Tepmongkol S, Keelawat S, Techavijit U, et al
    Clinical association of CXCR4 in primary tumor of papillary thyroid cancer and response to iodine-131 treatment.
    Nucl Med Commun. 2021;42:396-401.
    PubMed     Abstract available


  26. SHIN S, Kim K, Nam HY, Kim IJ, et al
    Sex difference in cerebral blood flow and cerebral glucose metabolism: an activation-likelihood estimation meta-analysis.
    Nucl Med Commun. 2021;42:410-415.
    PubMed     Abstract available


    March 2021
  27. KUMAR N, Deo S, Bhoriwal S, Sharma A, et al
    Comparison of treatment response assessed by 18F-FDG PET/CT with the histopathological response using tumor regression grading on surgically resected specimen following neoadjuvant chemotherapy in squamous cell carcinoma of esophagus.
    Nucl Med Commun. 2021 Mar 30. pii: 00006231-900000000-98043.
    PubMed     Abstract available


  28. FALAY O, Selcukbiricik F, Tanju S, Erus S, et al
    The prediction of spread through air spaces with preoperative 18F-FDG PET/CT in cases with primary lung adenocarcinoma, its effect on the decision for an adjuvant treatment and its prognostic role.
    Nucl Med Commun. 2021 Mar 30. pii: 00006231-900000000-98042.
    PubMed     Abstract available


  29. REILLY C, Gemmell AJ, McLaughlin IM, Fleming R, et al
    Characterisation of 99mTc EDDA/HYNIC-TOC (Tektrotyd) physiological and neuroendocrine tumour uptake using SPECT/CT standardised uptake values: initial experience.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98060.
    PubMed     Abstract available


  30. D'ABADIE P, Walrand S, Hesse M, Annet L, et al
    Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98058.
    PubMed     Abstract available


  31. GARZA D, Kandathil A, Xi Y, Subramaniam RM, et al
    18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98057.
    PubMed     Abstract available


  32. SHIBUTANI T, Onoguchi M, Yoneyama H, Konishi T, et al
    Performance of SwiftScan planar and SPECT technology using low-energy high-resolution and sensitivity collimator compared with Siemens SPECT system.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98056.
    PubMed     Abstract available


  33. GAO YJ, Yang Z, Yu JY, Li N, et al
    Potential application value of PET/computed tomography in retroperitoneal leiomyosarcoma and a literature review.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98054.
    PubMed     Abstract available


  34. PARIDA GK, Panda RA, Agrawal K
    Impact of fluorine-18-fluorodeoxyglucose PET/computed tomography in staging of patients with gallbladder cancer: a systematic review and meta-analysis.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98053.
    PubMed     Abstract available


  35. JIANG Y, Hou G, Zhu Z, Huo L, et al
    18F-FDG PET/CT imaging features of patients with multicentric Castleman disease.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98052.
    PubMed     Abstract available


  36. CHHABRA A, Shukla J, Sharma U, Vatsa R, et al
    Re-188-tricarbonyl tamoxifen as a theranostic radiopharmaceutical for estrogen receptor expressing breast cancers: radiolabeling, characterization and in-vitro cytotoxic assessment.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98051.
    PubMed     Abstract available


  37. SINGH TP, Sharma A, Sharma A, Bakhshi S, et al
    Utility of 18F-FDG-PET/CT in management and prognostication of treatment naive late-stage soft tissue sarcomas.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98050.
    PubMed     Abstract available


  38. MAPELLI P, Callea M, Fallanca F, Castellano A, et al
    18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98049.
    PubMed     Abstract available


  39. QUARTUCCIO N, Salem A, Laudicella R, Spataro A, et al
    The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98048.
    PubMed     Abstract available


  40. ORITA E, Becker D, Mueller M, Hefti M, et al
    FDG-PET/CT: novel method for viability assessment of livers perfused ex vivo.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98047.
    PubMed     Abstract available


  41. BARATTO L, Wu F, Minamimoto R, Hatami N, et al
    Correlation of 18-fluorodeoxyglucose PET/computed tomography parameters and clinical features to predict outcome for diffuse large B-cell lymphoma.
    Nucl Med Commun. 2021 Mar 18. pii: 00006231-900000000-98046.
    PubMed     Abstract available


  42. BAIOMY A, Schellingerhout D, Chapin BF, Weinberg JS, et al
    Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer.
    Nucl Med Commun. 2021 Mar 12. pii: 00006231-900000000-98061.
    PubMed     Abstract available


  43. TEICHNER EM, You JC, Hriso C, Wintering NA, et al
    Alterations in cerebral glucose metabolism as measured by 18F-fluorodeoxyglucose-PET in patients with persistent postconcussion syndrome.
    Nucl Med Commun. 2021 Mar 3. pii: 00006231-900000000-98064.
    PubMed     Abstract available


  44. VOUILLARMET J, Tordo J, Moret M, Michon P, et al
    99mTc-white blood cell SPECT/CT to assess diabetic foot osteomyelitis remission: contribution of semi-quantitative scoring system.
    Nucl Med Commun. 2021 Mar 3. pii: 00006231-900000000-98063.
    PubMed     Abstract available


  45. JHA AK, Mithun S, Rangarajan V, Wee L, et al
    Emerging role of artificial intelligence in nuclear medicine.
    Nucl Med Commun. 2021 Mar 1. pii: 00006231-900000000-98069.
    PubMed     Abstract available


  46. LIU H, Dang H, Wang R, Yao S, et al
    Analysis of the F-18 FDG PET/CT features of pulmonary sclerosing pneumocytoma.
    Nucl Med Commun. 2021 Mar 1. pii: 00006231-900000000-98068.
    PubMed     Abstract available


  47. AUJAY G, Debordeaux F, Blanc JF, Lapuyade B, et al
    18F-choline PET-computed tomography for the prediction of early treatment responses to transarterial radioembolization in patients with hepatocellular carcinoma.
    Nucl Med Commun. 2021 Mar 1. pii: 00006231-900000000-98067.
    PubMed     Abstract available


  48. AL-IBRAHEEM A, Abuhijla F, Salah S, Shahait M, et al
    The influence of 68Ga-prostate-specific membrane antigen PET/computed tomography on prostate cancer staging and planning of definitive radiation therapy.
    Nucl Med Commun. 2021 Mar 1. pii: 00006231-900000000-98066.
    PubMed     Abstract available


    February 2021
  49. CHOI EK, Oh JK, Seo YY, Im JJ, et al
    Prognostic value of pretreatment F-18 fluorodeoxyglucose PET/CT in colorectal cancer with unresectable metastasis.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98080.
    PubMed     Abstract available


  50. AGRAWAL K, Padhy BM, Meher BR, Mohanty RR, et al
    Diagnostic utility of Ga-68 DOTA-SSTR and F-18 FDG PET/CT in the detection of culprit tumours causing osteomalacia: a systematic review and meta-analysis.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98078.
    PubMed     Abstract available


  51. OZMEN O, Tatci E, Demiroz SM, Tazeler Z, et al
    Is 18F-FDG PET/CT capable of differential diagnosis from tuberculous pleurisy from malignant mesothelioma?
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98075.
    PubMed     Abstract available


  52. YOO SW, Kim DY, Pyo A, Jeon S, et al
    Differences in diagnostic impact of dual-tracer PET/computed tomography according to the extrahepatic metastatic site in patients with hepatocellular carcinoma.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98074.
    PubMed     Abstract available


  53. LIU ZF, Ye QN, Yang J, Yang M, et al
    Preclinical evaluation of [68Ga]Ga-MALAT-1-antisense oligonucleotides for specific PET imaging of MALAT-1 expressing tumours.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98072.
    PubMed     Abstract available


  54. WONG JM, Puri T, Siddique MM, Frost ML, et al
    Comparison of ordered-subset expectation maximization and filtered back projection reconstruction based on quantitative outcome from dynamic [18F]NaF PET images.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98071.
    PubMed     Abstract available


  55. KIM JS, Park CR, Yoon SH, Lee JA, et al
    Improvement of image quality using amplitude-based respiratory gating in PET-computed tomography scanning.
    Nucl Med Commun. 2021 Feb 19. pii: 00006231-900000000-98070.
    PubMed     Abstract available


  56. SHARMA A, Phulia A, Sethi RS
    PET/computed tomography enterography.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98088.
    PubMed     Abstract available


  57. MOHAMADIEN NRA, Sayed MHM
    Correlation between semiquantitative and volumetric 18F-FDG PET/computed tomography parameters and Ki-67 expression in breast cancer.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98087.
    PubMed     Abstract available


  58. ADNAN A, Basu S
    Concept proposal for a six-tier integrated dual tracer PET-CT (68Ga-PSMA and FDG) image scoring system ('Pro-PET' score) and examining its potential implications in metastatic castration-resistant prostate carcinoma theranostics and prognosis.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98085.
    PubMed     Abstract available


  59. AKSU A, Karahan Sen NP, Tuna EB, Aslan G, et al
    Evaluation of 68Ga-PSMA PET/CT with volumetric parameters for staging of prostate cancer patients.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98084.
    PubMed     Abstract available


  60. MATHEW B, Purandare NC, Pramesh CS, Karimundackal G, et al
    Improving accuracy of 18F-fluorodeoxyglucose PET computed tomography to diagnose nodal involvement in non-small cell lung cancer: utility of using various predictive models.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98083.
    PubMed     Abstract available


  61. WAKFIE-CORIEH CG, Rodriguez Rey C, Ortega Candil A, Ferrando-Castagnetto F, et al
    Clinical relevance of incidental focal breast uptake on fluorine-18 fluorodeoxyglucose PET/computed tomography studies: an experience in a high-load center of Spain.
    Nucl Med Commun. 2021 Feb 5. pii: 00006231-900000000-98082.
    PubMed     Abstract available


    January 2021
  62. KOHLENBERG JD, Panda A, Johnson GB, Castro MR, et al
    Radiologic and clinicopathologic characteristics of thyroid nodules with focal 68Ga-DOTATATE PET activity.
    Nucl Med Commun. 2021 Jan 19. pii: 00006231-900000000-98093.
    PubMed     Abstract available


  63. THAKAR A, Sakthivel P, Arunraj ST, Bhalla AS, et al
    Clinical utility of Ga68 DOTANOC PET/CT imaging in juvenile nasal angiofibroma and the PARIS protocol: a preliminary report.
    Nucl Med Commun. 2021 Jan 19. pii: 00006231-900000000-98092.
    PubMed     Abstract available


  64. MINGELS C, Sachpekidis C, Bohn KP, Hunermund JN, et al
    The influence of colour scale in lesion detection and patient-based sensitivity in [68Ga]Ga-PSMA-PET/CT.
    Nucl Med Commun. 2021 Jan 19. pii: 00006231-900000000-98091.
    PubMed     Abstract available


  65. CHEN B, Zhang H, Liu D, Wang X, et al
    Diagnostic performance of 18F-FDG PET/CT for the detection of occult primary tumors in squamous cell carcinoma of unknown primary in the head and neck: a single-center retrospective study.
    Nucl Med Commun. 2021 Jan 19. pii: 00006231-900000000-98090.
    PubMed     Abstract available


  66. SONG Y, Wang PY, Zheng Y, Liu C, et al
    Expression of TIGAR and its correlation with clinicopathology, prognosis, and 18F-FDG PET/CT parameters in patients with resectable pancreatic ductal adenocarcinoma.
    Nucl Med Commun. 2021 Jan 19. pii: 00006231-900000000-98089.
    PubMed     Abstract available


  67. OZGUVEN S, Ones T, Bozkurtlar E, Yanartas M, et al
    Chronic thromboembolic pulmonary hypertension: evaluation of V/Q SPECT/CT and V/Q Quotient SPECT findings with postoperative results of pulmonary endarterectomy.
    Nucl Med Commun. 2021 Jan 11. pii: 00006231-900000000-98094.
    PubMed     Abstract available


    December 2020
  68. MALIHA PG, Singerman J, Abikhzer G, Probst S, et al
    Physiologic prostate-specific membrane antigen-targeted 18F-DCFPyL uptake in the epididymis head newly appreciated on digital PET/CT.
    Nucl Med Commun. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  69. SINGH B, Sharma S, Bansal P, Hooda M, et al
    Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality.
    Nucl Med Commun. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  70. DIZDAREVIC S, Abdulla M, Sewedy T, Weston C, et al
    Impact of COVID-19 on nuclear medicine in the UK.
    Nucl Med Commun. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  71. BATTAL H, Ozer AY
    Adverse reactions to radiopharmaceuticals: liver radiopharmaceuticals.
    Nucl Med Commun. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  72. MOSTAFA R, Abdelhafez YG, Abougabal M, Nardo L, et al
    Two-bed SPECT/CT versus planar bone scintigraphy: prospective comparison of reproducibility and diagnostic performance.
    Nucl Med Commun. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  73. BORJA AJ, Hancin EC, Zhang V, Koa B, et al
    Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk.
    Nucl Med Commun. 2020 Dec 14. doi: 10.1097/MNM.0000000000001349.
    PubMed     Abstract available


  74. HOEKSTRA RJ, Beulens A, Vrijhof EHJEJ, Wyndaele DNJ, et al
    Diagnostic accuracy of 18F-fluciclovine PET/CT in primary lymph node staging of prostate cancer.
    Nucl Med Commun. 2020 Dec 14. doi: 10.1097/MNM.0000000000001352.
    PubMed     Abstract available


  75. JIN J, Wu K, Li X, Yu Y, et al
    Relationship between tumor heterogeneity and volume in cervical cancer: Evidence from integrated fluorodeoxyglucose 18 PET/MR texture analysis.
    Nucl Med Commun. 2020 Dec 14. doi: 10.1097/MNM.0000000000001354.
    PubMed     Abstract available


  76. WU D, Plyku D, Kulkarni K, Garcia C, et al
    The spectrum of 124I uptake in the lacrimal gland and nasolacrimal sac/duct on PET/CT imaging.
    Nucl Med Commun. 2020 Dec 14. doi: 10.1097/MNM.0000000000001330.
    PubMed     Abstract available


  77. WONG WL, Ross P, Peters K, Frenz M, et al
    The COVID-19 pandemic: impact on NHS England PET-CT services and lessons learnt.
    Nucl Med Commun. 2020 Dec 10. doi: 10.1097/MNM.0000000000001346.
    PubMed     Abstract available


  78. AKDENIZ N, Komek H, Kucukoner M, Kaplan MA, et al
    The role of basal 18F-FDG PET/CT maximum standard uptake value and maximum standard uptake change in predicting pathological response in breast cancer patients receiving neoadjuvant chemotherapy.
    Nucl Med Commun. 2020 Dec 10. doi: 10.1097/MNM.0000000000001332.
    PubMed     Abstract available


  79. TUSTUMI F, Duarte PS, Albenda DG, Takeda FR, et al
    Prognostic value of 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters measured in the primary tumor and suspicious lymph nodes before neoadjuvant therapy in patients with esophageal carcinoma.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001347.
    PubMed     Abstract available


  80. WAN QC, Li JF, Tang LL, Lv J, et al
    Comparing the diagnostic accuracy of 4D CT and 99mTc-MIBI SPECT/CT for localizing hyperfunctioning parathyroid glands: a systematic review and meta-analysis.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001331.
    PubMed     Abstract available


  81. FUENTES-OCAMPO F, Lopez-Mora DA, Flotats A, Camacho V, et al
    Digital versus analog PET/CT in patients with known or suspected liver metastases.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001341.
    PubMed     Abstract available


  82. RODRIGUEZ TAROCO MG, Cuna EG, Pages C, Schelotto M, et al
    Prognostic value of imaging markers from 18FDG-PET/CT in paediatric patients with Hodgkin lymphoma.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001337.
    PubMed     Abstract available


  83. AYUBCHA C, Raynor WY, Borja AJ, Seraj SM, et al
    Magnetic resonance imaging-based partial volume-corrected 18F-sodium fluoride positron emission tomography in the femoral neck.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001344.
    PubMed     Abstract available


  84. JAIN TK, Singh G, Goyal S, Malhotra H, et al
    Is F-18 FDG PET/computed tomography a useful tool to restage the patients with tongue carcinoma?
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001336.
    PubMed     Abstract available


  85. ZHANG LZ, Li S, Jiang Y, Qiu ZL, et al
    Clinical usefulness of single photon emission tomography/computed tomography with stress analysis in early diagnoses of stem instability of noncemented hip arthroplasty.
    Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.0000000000001323.
    PubMed     Abstract available


    November 2020
  86. PRAKASH S, Kumar R, Vinjamuri S
    What role does 18F-fluorodeoxyglucose PET-computed tomography have in the current pandemic and beyond?
    Nucl Med Commun. 2020 Nov 27. doi: 10.1097/MNM.0000000000001320.
    PubMed    


  87. FLAUS A, Nevesny S, Guy JB, Sotton S, et al
    Positron emission tomography for radiotherapy planning in head and neck cancer: What impact?
    Nucl Med Commun. 2020 Nov 27. doi: 10.1097/MNM.0000000000001329.
    PubMed     Abstract available


  88. JU H, Paycha F
    Osteoblastic and hyperostotic craniofacial lesion detected by 99mTc-labeled methylene diphosphonate bone scintigraphy and single-photon emission computed tomography/computed tomography: a pictorial essay.
    Nucl Med Commun. 2020 Nov 5. doi: 10.1097/MNM.0000000000001318.
    PubMed     Abstract available


  89. PANDA A, Hintermeister HA, Hunt CH, Kendi AT, et al
    Whole-body 18-F-FDG-PET in patients with leptomeningeal disease and correlation with MRI.
    Nucl Med Commun. 2020 Nov 5. doi: 10.1097/MNM.0000000000001317.
    PubMed     Abstract available


  90. KANDEEL A, Saied M, Aldaly M, Darwish H, et al
    Impact of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography on the initial staging and changing the management intent in head and neck squamous cell carcinoma.
    Nucl Med Commun. 2020 Nov 5. doi: 10.1097/MNM.0000000000001316.
    PubMed     Abstract available


  91. LOCOCO F, Sassorossi C, Chiappetta M, Cesario A, et al
    Correlation between 18F-FDG PET/computer tomography findings and histology in thymic epithelial tumors: current evidences and clinical implications.
    Nucl Med Commun. 2020;41:1221-1222.
    PubMed    


    October 2020
  92. HANSEN SL, Bebbington NA
    Estimation of CARE Dose 4D quality reference mAs conversion factors for child to adult reference patient in child protocols on Siemens Symbia SPECT-CT systems.
    Nucl Med Commun. 2020 Oct 16. doi: 10.1097/MNM.0000000000001312.
    PubMed     Abstract available


  93. ANDERSEN JD, Zacho HD, Petersen LJ
    The frequency and malignancy rate of incidental focal breast lesions identified by 18F-fluorodeoxyglucose positron emission tomography.
    Nucl Med Commun. 2020 Oct 9. doi: 10.1097/MNM.0000000000001309.
    PubMed     Abstract available


  94. ISHIWATA Y, Kaneta T, Nawata S, Iizuka H, et al
    Feasibility of prognosis assessment for cancer of unknown primary origin using texture analysis of 18F-fluorodeoxyglucose PET/computed tomography images of largest metastatic lymph node.
    Nucl Med Commun. 2020 Oct 9. doi: 10.1097/MNM.0000000000001310.
    PubMed     Abstract available


  95. LEE HJ, Lim HS, Ki SY, Park HM, et al
    18F-fluorodeoxyglucose uptake on PET/computed tomography in association with androgen receptor expression and other clinicopathologic factors in surgically resected triple-negative breast cancer.
    Nucl Med Commun. 2020 Oct 9. doi: 10.1097/MNM.0000000000001300.
    PubMed     Abstract available


  96. ZHANG L, Chen J, Xu C, Zhang Y, et al
    The value of 4D fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of lung lesions.
    Nucl Med Commun. 2020 Oct 9. doi: 10.1097/MNM.0000000000001289.
    PubMed     Abstract available


  97. UGUR A, Yaylali O, Yuksel D
    Examination of metallic impurities of 68Ge/68Ga generators used for radioactive labeling of peptides in clinical PET applications.
    Nucl Med Commun. 2020 Oct 9. doi: 10.1097/MNM.0000000000001307.
    PubMed     Abstract available


  98. DINET J, Tonnelet D, Le Cloirec J, Becker S, et al
    Red cell volume measurement: using technetium as a replacement for chromium.
    Nucl Med Commun. 2020;41:1106-1107.
    PubMed    


  99. MAPELLI P, Ironi G, Bergamini A, Mangili G, et al
    Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer.
    Nucl Med Commun. 2020;41:1073-1080.
    PubMed     Abstract available



  100. British Nuclear Medicine Society Autumn Meeting 2020.
    Nucl Med Commun. 2020;41:1109-1110.
    PubMed    


    September 2020
  101. KATAL S, Amini H, Gholamrezanezhad A
    PET in the diagnostic management of infectious/inflammatory pulmonary pathologies: a revisit in the era of COVID-19.
    Nucl Med Commun. 2020 Sep 24. doi: 10.1097/MNM.0000000000001299.
    PubMed    


  102. TASDEMIR B, Guzel Y, Komek H, Can C, et al
    Evaluation of dual time-point fluorodeoxyglucose PET/computed tomography imaging in gastric cancer.
    Nucl Med Commun. 2020 Sep 21. doi: 10.1097/MNM.0000000000001290.
    PubMed     Abstract available


  103. LIU Y, Wang G, Yu H, Wu Y, et al
    Comparison of 18F-DCFPyL and 18F-FDG PET/computed tomography for the restaging of clear cell renal cell carcinoma: preliminary results of 15 patients.
    Nucl Med Commun. 2020 Sep 15. doi: 10.1097/MNM.0000000000001285.
    PubMed     Abstract available


  104. SASIDHARAN A, Murthy V, Natarajan A, Agarwal A, et al
    Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI.
    Nucl Med Commun. 2020 Sep 15. doi: 10.1097/MNM.0000000000001283.
    PubMed     Abstract available


  105. KIM K, Kim SJ
    Diagnostic performance of F-18 fluorodeoxyglucose PET/computed tomography for diagnosis of polymyalgia rheumatica: a meta-analysis.
    Nucl Med Commun. 2020 Sep 15. doi: 10.1097/MNM.0000000000001292.
    PubMed     Abstract available


  106. SAGHEB S, Metser U, Razaz S, Menezes R, et al
    Preliminary evaluation of 18F-FDG-PET/MRI for differentiation of serous from nonserous pancreatic cystic neoplasms: a pilot study.
    Nucl Med Commun. 2020 Sep 5. doi: 10.1097/MNM.0000000000001277.
    PubMed     Abstract available


  107. LUO Y, Zhang Y, Pan Q, Zhang Y, et al
    18F-FDG PET/computed tomography may predict the outcome of newly diagnosed indolent non-Hodgkin lymphoma in patients managed with initial 'watch-and-wait' approach.
    Nucl Med Commun. 2020 Sep 5. doi: 10.1097/MNM.0000000000001279.
    PubMed     Abstract available


  108. VADALA M, Cistaro A, Quartuccio N, Calcagni ML, et al
    18F-FDG-PET brain imaging may highlight brain metabolic alterations in dysautonomic syndrome after human papilloma virus vaccination.
    Nucl Med Commun. 2020 Sep 3. doi: 10.1097/MNM.0000000000001280.
    PubMed     Abstract available


  109. VOO S, Dizdarevic S
    Single photon emission computed tomography lung perfusion imaging during the COVID-19 pandemic: does nuclear medicine need to reconsider its guidelines?
    Nucl Med Commun. 2020;41:991-993.
    PubMed    


  110. SANGHERA B, Fenwick A, Lowe G, Sullivan K, et al
    Radionuclide calibrator intercomparison study of clinical PET centres in England to a single traceable 68Ge syringe source.
    Nucl Med Commun. 2020;41:965-976.
    PubMed     Abstract available


  111. PANDE SS, Purandare N, Puranik A, Shah S, et al
    Role of 18F-FDG PET/CT in restaging of esophageal cancer after curative-intent surgical resection.
    Nucl Med Commun. 2020;41:959-964.
    PubMed     Abstract available


  112. ZHONG X, Diao W, Zhao C, Jia Z, et al
    Fluorodeoxyglucose-avid focal lesions and extramedullary disease on 18F-FDG PET/computed tomography predict the outcomes of newly diagnosed symptomatic multiple myeloma patients.
    Nucl Med Commun. 2020;41:950-958.
    PubMed     Abstract available


  113. XIAO J, Wang D, Guo B, Wang L, et al
    Observer agreement and accuracy of 18F-sodium fluoride PET/computed tomography in the diagnosis of skull-base bone invasion and osseous metastases in newly diagnosed nasopharyngeal carcinoma.
    Nucl Med Commun. 2020;41:942-949.
    PubMed     Abstract available


  114. XIAO J, Hu B, Cheng D, Shi H, et al
    Features of IgG4-related lung disease on 18F-FDG PET/computed tomography imaging.
    Nucl Med Commun. 2020;41:933-941.
    PubMed     Abstract available


  115. YADAV D, Shamim SA, Rastogi S, Upadhyay DMR, et al
    Role of 18F-FDG PET/computed tomography in prognostication and management of malignant peripheral nerve sheath tumors.
    Nucl Med Commun. 2020;41:924-932.
    PubMed     Abstract available


  116. GRUT H, Stern NM, Dueland S, Labori KJ, et al
    Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases.
    Nucl Med Commun. 2020;41:916-923.
    PubMed     Abstract available


  117. TEYATEETI A, Khan B, Teyateeti A, Chen B, et al
    Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level
    Nucl Med Commun. 2020;41:906-915.
    PubMed     Abstract available


  118. MAPELLI P, Partelli S, Salgarello M, Doraku J, et al
    Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: an endearing tool for preoperative risk assessment.
    Nucl Med Commun. 2020;41:896-905.
    PubMed     Abstract available


  119. PAWAR SU, Ravat SH, Muzumdar DP, Sankhe SS, et al
    Does Tc-99m ECD ictal brain SPECT have incremental value in localization of epileptogenic zone and predicting postoperative seizure freedom in cases with discordant video electroencephalogram and MRI findings?
    Nucl Med Commun. 2020;41:858-870.
    PubMed     Abstract available


  120. RANI N, Singh B, Kumar N, Singh P, et al
    The diagnostic performance of 99mTc-methionine single-photon emission tomography in grading glioma preoperatively: a comparison with histopathology and Ki-67 indices.
    Nucl Med Commun. 2020;41:848-857.
    PubMed     Abstract available


  121. SHIRI I, Abdollahi H, Atashzar MR, Rahmim A, et al
    A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease.
    Nucl Med Commun. 2020;41:837-840.
    PubMed    


    August 2020
  122. HENRIKSEN OM, Holm S, Marner L, Law I, et al
    Effect of blood glucose and body weight on image quality in brain [18F]FDG PET imaging.
    Nucl Med Commun. 2020 Aug 27. doi: 10.1097/MNM.0000000000001281.
    PubMed     Abstract available


  123. SATO S, Fujiwara S, Miyoshi K, Chida K, et al
    Improvement in gait function after carotid endarterectomy is associated with postoperative recovery in perfusion and neurotransmitter receptor function in the motor-related cerebral cortex: a 123I-iomazenil SPECT study.
    Nucl Med Commun. 2020 Aug 18. doi: 10.1097/MNM.0000000000001275.
    PubMed     Abstract available


  124. LIAO X, Cui Y, Chen X, Di L, et al
    Primary metabolic tumor volume from 18F-FDG PET/CT associated with epidermal growth factor receptor mutation in lung adenocarcinoma patients.
    Nucl Med Commun. 2020 Aug 18. doi: 10.1097/MNM.0000000000001274.
    PubMed     Abstract available


  125. TELO S, Fanti S, Nanni C, Lambertini A, et al
    Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL.
    Nucl Med Commun. 2020 Aug 13. doi: 10.1097/MNM.0000000000001266.
    PubMed     Abstract available


  126. GABRIELSON S, Tsai JA, Celebioglu F, Nilsson M, et al
    Preoperative detection of sentinel lymph nodes with hybrid SPECT/computed tomography imaging may improve the accuracy of sentinel lymph node biopsies in patients with early stages of cancer of the oesophagus or gastro-oesophageal junction.
    Nucl Med Commun. 2020 Aug 11. doi: 10.1097/MNM.0000000000001273.
    PubMed     Abstract available


  127. AYDOS U, Tahtaci G, Ozgur Akdemir U, Ozet A, et al
    18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters.
    Nucl Med Commun. 2020 Aug 10. doi: 10.1097/MNM.0000000000001272.
    PubMed     Abstract available


  128. YAMANAKA M, Shinya T, Otomi Y, Kubo M, et al
    Semiquantitative assessment of fluorodeoxyglucose uptake in primary tumours on dynamic PET/computed tomography for lymph node metastasis evaluation in patients with lung cancer: a prospective study.
    Nucl Med Commun. 2020 Aug 10. doi: 10.1097/MNM.0000000000001271.
    PubMed     Abstract available


  129. RAJU S, Sharma A, Patel C, Sahoo R, et al
    Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
    Nucl Med Commun. 2020 Aug 10. doi: 10.1097/MNM.0000000000001268.
    PubMed     Abstract available


  130. KASALAK O, Yakar D, Dierckx RAJO, Kwee TC, et al
    Patient safety in nuclear medicine: identification of key strategic areas for vigilance and improvement.
    Nucl Med Commun. 2020 Aug 4. doi: 10.1097/MNM.0000000000001262.
    PubMed     Abstract available


    July 2020
  131. DE MOOIJ CM, Sunen I, Mitea C, Lalji UC, et al
    Diagnostic performance of PET/computed tomography versus PET/MRI and diffusion-weighted imaging in the N- and M-staging of breast cancer patients.
    Nucl Med Commun. 2020 Jul 28. doi: 10.1097/MNM.0000000000001254.
    PubMed     Abstract available


  132. MOSCI C, Pericole FV, Oliveira GB, Delamain MT, et al
    99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma.
    Nucl Med Commun. 2020 Jul 23. doi: 10.1097/MNM.0000000000001259.
    PubMed     Abstract available


  133. SINGH D, Shukla J, Walia R, Vatsa R, et al
    Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001251.
    PubMed     Abstract available


  134. MALIHA PG, Singerman J, Probst S
    Weight loss as primary indication for FDG-PET/CT.
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001250.
    PubMed     Abstract available


  135. YOU H, Kandathil A, Beg M, De Blanche L, et al
    Ga-68 DOTATATE PET/CT and F-18 FDG PET/CT in the evaluation of low and intermediate versus high-grade neuroendocrine tumors.
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001255.
    PubMed     Abstract available


  136. FILIPPI L, Fontana A, Spinelli GP, Rossi L, et al
    Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma.
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001260.
    PubMed     Abstract available


  137. MENON BK, Kalshetty A, Bhattacharjee A, Basu S, et al
    Standardized uptake values and ratios on 68Ga-DOTATATE PET-computed tomography for normal organs and malignant lesions and their correlation with Krenning score in patients with metastatic neuroendocrine tumors.
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001253.
    PubMed     Abstract available


  138. PURANDARE NC, Puranik A, Agrawal A, Shah S, et al
    Does 68Ga-DOTA-NOC-PET/CT impact staging and therapeutic decision making in pulmonary carcinoid tumors?
    Nucl Med Commun. 2020 Jul 21. doi: 10.1097/MNM.0000000000001248.
    PubMed     Abstract available


  139. COCKBURN N, Corsaut J, Kovacs MS, St Lawrence K, et al
    Validation protocol for current good manufacturing practices production of [15O]water for hybrid PET/MR studies.
    Nucl Med Commun. 2020 Jul 14. doi: 10.1097/MNM.0000000000001249.
    PubMed     Abstract available


  140. LABEUR TA, Cieslak KP, Van Gulik TM, Takkenberg RB, et al
    The utility of 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT/CT for selective internal radiation therapy in hepatocellular carcinoma.
    Nucl Med Commun. 2020 Jul 3. doi: 10.1097/MNM.0000000000001224.
    PubMed     Abstract available


  141. VOO S, Dizdarevic S
    Single photon emission computed tomography-computed tomography lung perfusion imaging during the COVID-19 pandemic: does nuclear medicine need to reconsider its guidelines?
    Nucl Med Commun. 2020 Jul 3. doi: 10.1097/MNM.0000000000001246.
    PubMed    


  142. XIAO J, Wang D, Guo B, Wang L, et al
    Observer agreement and accuracy of 18F-sodium fluoride PET/computed tomography in the diagnosis of skull-base bone invasion and osseous metastases in newly diagnosed nasopharyngeal carcinoma.
    Nucl Med Commun. 2020 Jul 3. doi: 10.1097/MNM.0000000000001243.
    PubMed     Abstract available


  143. HANSROD S, James G, Notghi A, Croasdale J, et al
    Gastric emptying: methodology and normal ranges for two commonly used meals in the UK.
    Nucl Med Commun. 2020;41:636-650.
    PubMed     Abstract available


  144. FENG L, Zhang Z, Malam Djibo I, Chen S, et al
    The efficacy of single-photon emission computed tomography in identifying dystonic muscles in cervical dystonia.
    Nucl Med Commun. 2020;41:651-658.
    PubMed     Abstract available


  145. GUNER LA, Unal K, Vardareli E, Kaya E, et al
    Physiological fluorodeoxyglucose uptake of spinal cord in adults.
    Nucl Med Commun. 2020;41:659-665.
    PubMed     Abstract available


  146. FUJIWARA K, Akiba H, Tsuji AB, Sudo H, et al
    64Cu-labeled minibody D2101 visualizes CDH17-positive gastric cancer xenografts with short waiting time.
    Nucl Med Commun. 2020;41:688-695.
    PubMed     Abstract available


  147. JOHNSON S, Gulliver N, King S, Meadows A, et al
    Technical note on the administration of intravenous contrast media in hybrid imaging.
    Nucl Med Commun. 2020;41:706-713.
    PubMed     Abstract available


    June 2020
  148. SANGHERA B, Fenwick A, Lowe G, Sullivan K, et al
    Radionuclide calibrator intercomparison study of clinical PET centres in England to a single traceable 68Ge syringe source.
    Nucl Med Commun. 2020 Jun 23. doi: 10.1097/MNM.0000000000001241.
    PubMed     Abstract available


  149. YADAV D, Shamim SA, Rastogi S, Upadhyay DMR, et al
    Role of 18F-FDG PET/computed tomography in prognostication and management of malignant peripheral nerve sheath tumors.
    Nucl Med Commun. 2020 Jun 23. doi: 10.1097/MNM.0000000000001237.
    PubMed     Abstract available


  150. ZHONG X, Diao W, Zhao C, Jia Z, et al
    Fluorodeoxyglucose-avid focal lesions and extramedullary disease on 18F-FDG PET/computed tomography predict the outcomes of newly diagnosed symptomatic multiple myeloma patients.
    Nucl Med Commun. 2020 Jun 23. doi: 10.1097/MNM.0000000000001242.
    PubMed     Abstract available


  151. PAWAR SU, Ravat SH, Muzumdar DP, Sankhe SS, et al
    Does Tc-99m ECD ictal brain SPECT have incremental value in localization of epileptogenic zone and predicting postoperative seizure freedom in cases with discordant video electroencephalogram and MRI findings?
    Nucl Med Commun. 2020 Jun 23. doi: 10.1097/MNM.0000000000001240.
    PubMed     Abstract available


  152. MAPELLI P, Partelli S, Salgarello M, Doraku J, et al
    Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: an endearing tool for preoperative risk assessment.
    Nucl Med Commun. 2020 Jun 18. doi: 10.1097/MNM.0000000000001236.
    PubMed     Abstract available


  153. PANDE SS, Purandare N, Puranik A, Shah S, et al
    Role of 18F-FDG PET/CT in restaging of esophageal cancer after curative-intent surgical resection.
    Nucl Med Commun. 2020 Jun 18. doi: 10.1097/MNM.0000000000001229.
    PubMed     Abstract available


  154. RANI N, Singh B, Kumar N, Singh P, et al
    The diagnostic performance of 99mTc-methionine single-photon emission tomography in grading glioma preoperatively: a comparison with histopathology and Ki-67 indices.
    Nucl Med Commun. 2020 Jun 18. doi: 10.1097/MNM.0000000000001230.
    PubMed     Abstract available


  155. GRUT H, Stern NM, Dueland S, Labori KJ, et al
    Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases.
    Nucl Med Commun. 2020 Jun 18. doi: 10.1097/MNM.0000000000001235.
    PubMed     Abstract available


  156. XIAO J, Hu B, Cheng D, Shi H, et al
    Features of IgG4-related lung disease on 18F-FDG PET/computed tomography imaging.
    Nucl Med Commun. 2020 Jun 17. doi: 10.1097/MNM.0000000000001238.
    PubMed     Abstract available


  157. KITAJIMA K, Maruyama M, Minami T, Yokoi T, et al
    Comparison of modified Response Evaluation Criteria in Solid Tumors, European Organization for Research and Treatment of Cancer criteria, and PET Response Criteria in Solid Tumors for evaluation of tumor response to chemotherapy and prognosis predicti
    Nucl Med Commun. 2020 Jun 8. doi: 10.1097/MNM.0000000000001223.
    PubMed     Abstract available


  158. TEYATEETI A, Khan B, Teyateeti A, Chen B, et al
    Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level
    Nucl Med Commun. 2020 Jun 8. doi: 10.1097/MNM.0000000000001228.
    PubMed     Abstract available


  159. ONNER H, Abdulrezzak U, Tutus A
    Could the skewness and kurtosis texture parameters of lesions obtained from pretreatment Ga-68 DOTA-TATE PET/CT images predict receptor radionuclide therapy response in patients with gastroenteropancreatic neuroendocrine tumors?
    Nucl Med Commun. 2020 Jun 8. doi: 10.1097/MNM.0000000000001231.
    PubMed     Abstract available


  160. CASTANHEIRA J, Mascarenhas Gaivao A, Mairos Teixeira S, Pereira PJ, et al
    Asymptomatic COVID-19 positive patient suspected on FDG-PET/CT.
    Nucl Med Commun. 2020;41:598-599.
    PubMed    


  161. VOO S, Neriman D, Henry M, Kayani I, et al
    Perfusion-ventilation imaging in an era of COVID-19.
    Nucl Med Commun. 2020;41:597-598.
    PubMed    


  162. SYED A, Levart D, Vadrucci M, Gibson V, et al
    Absence of hepatic activity in lymphoscintigraphy performed with Tc-99m-Nanoscan.
    Nucl Med Commun. 2020;41:505-509.
    PubMed     Abstract available


  163. DUMONT SM, Costa HS, Chaves AT, Nunes MDCP, et al
    Radionuclide esophageal transit scintigraphy in chronic indeterminate and cardiac forms of Chagas disease.
    Nucl Med Commun. 2020;41:510-516.
    PubMed     Abstract available


    May 2020
  164. MANABE O, Klein R, Katoh C, Magota K, et al
    Validation of regional myocardial blood flow quantification using three-dimensional PET with rubidium-82: repeatability and comparison with two-dimensional PET data acquisition.
    Nucl Med Commun. 2020 May 25. doi: 10.1097/MNM.0000000000001218.
    PubMed     Abstract available


  165. AYDOS U, Arhan E, Akdemir UO, Akbas Y, et al
    Utility of brain fluorodeoxyglucose PET in children with possible autoimmune encephalitis.
    Nucl Med Commun. 2020 May 25. doi: 10.1097/MNM.0000000000001222.
    PubMed     Abstract available


  166. DEMIRCI E, Akyel R, Caner B, Alan-Selcuk N, et al
    Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria.
    Nucl Med Commun. 2020 May 21. doi: 10.1097/MNM.0000000000001219.
    PubMed     Abstract available


  167. BROOS WAM, Wondergem M, van der Zant FM, Schaper NC, et al
    Dynamic 18F-fluorocholine PET/CT for parathyroid imaging in patients with primary hyperparathyroidism.
    Nucl Med Commun. 2020 May 21. doi: 10.1097/MNM.0000000000001217.
    PubMed     Abstract available


  168. BROWN PH, Carter JR, Moyade P, Mohammed M, et al
    Real-world experience of the role of 18F FDG PET-computed tomography in chronic spinal implant infection.
    Nucl Med Commun. 2020 May 15. doi: 10.1097/MNM.0000000000001211.
    PubMed     Abstract available


  169. AKIN M, Orguc S, Aras F, Kandiloglu AR, et al
    Molecular subtypes of invasive breast cancer: correlation between PET/computed tomography and MRI findings.
    Nucl Med Commun. 2020 May 15. doi: 10.1097/MNM.0000000000001220.
    PubMed     Abstract available


  170. VAN DER ZANT FM, Maurits W, Lazarenko SV, Broos WAM, et al
    Relation between pharmacological stress ECG, 13NH3-PET/CT outcome and the occurrence of cardiac events during follow-up in women with chest pain.
    Nucl Med Commun. 2020 May 15. doi: 10.1097/MNM.0000000000001212.
    PubMed     Abstract available


  171. BIEG C, Mongelli F, Peterli R, Chirindel AF, et al
    Simplified dual time point FDG-PET/computed tomography for determining dignity of pancreatic lesions.
    Nucl Med Commun. 2020 May 8. doi: 10.1097/MNM.0000000000001191.
    PubMed     Abstract available


  172. GAZZILLI M, Albano D, Durmo R, Cerudelli E, et al
    Improvement of diagnostic accuracy of 18fluorine-fluorodeoxyglucose PET/computed tomography in detection of infective endocarditis using a 72-h low carbs protocol.
    Nucl Med Commun. 2020 May 8. doi: 10.1097/MNM.0000000000001208.
    PubMed     Abstract available


  173. MACNAB MF, Biggans TJ, Mckiddie FI, Pether MI, et al
    Detectability of small objects in PET/computed tomography phantom images with Bayesian penalised likelihood reconstruction.
    Nucl Med Commun. 2020 May 8. doi: 10.1097/MNM.0000000000001204.
    PubMed     Abstract available


  174. JIMENEZ LONDONO GA, Garcia Vicente AM, Noriega Alvarez E, Pena Pardo FJ, et al
    18F-choline PET/computed tomography and clinical parameters in the detection of significant prostate cancer in patients with increased prostate-specific antigen levels and previous negative biopsies.
    Nucl Med Commun. 2020 May 8. doi: 10.1097/MNM.0000000000001189.
    PubMed     Abstract available


  175. ZUCKIER LS, Gordon SR
    COVID-19 in the Nuclear Medicine Department, be prepared for ventilation scans as well!
    Nucl Med Commun. 2020;41:494-495.
    PubMed    


  176. TSUCHIYA J, Yoneyama T, Ohtake M, Tateishi K, et al
    Redox reaction and clinical outcome of primary diffuse large B-cell lymphoma of the central nervous system: Prognostic role of metabolic and textural parameters of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/computed tomography in a small patie
    Nucl Med Commun. 2020 May 1. doi: 10.1097/MNM.0000000000001197.
    PubMed     Abstract available


  177. CASTELLO A, Riva M, Fernandes B, Bello L, et al
    The role of 11C-methionine PET in patients with negative diffusion-weighted magnetic resonance imaging: correlation with histology and molecular biomarkers in operated gliomas.
    Nucl Med Commun. 2020 May 1. doi: 10.1097/MNM.0000000000001202.
    PubMed     Abstract available


  178. PIZZUTO DA, Husmann L, Stolzmann P, Meerwein C, et al
    Fluoro-deoxy-glucose uptake in the mylohyoid muscle: a common misconception.
    Nucl Med Commun. 2020;41:452-458.
    PubMed     Abstract available


  179. PANDEY AK, Santosh Y, Sharma PD, Yadav D, et al
    Restoration of I-131 whole body image using a Wiener filter.
    Nucl Med Commun. 2020;41:426-435.
    PubMed     Abstract available


    April 2020
  180. BUSCOMBE JR, Notghi A, Croasdale J, Pandit M, et al
    COVID-19: guidance for infection prevention and control in nuclear medicine.
    Nucl Med Commun. 2020 Apr 15. doi: 10.1097/MNM.0000000000001206.
    PubMed     Abstract available


  181. KULKARNI SC, Padma S, Shanmuga Sundaram P
    In the evaluation of patients with skull base osteomyelitis, does 18F-FDG PET CT have a role?
    Nucl Med Commun. 2020 Apr 10. doi: 10.1097/MNM.0000000000001187.
    PubMed     Abstract available


  182. ZHANG J, Ma G, Cheng J, Song S, et al
    Diagnostic classification of solitary pulmonary nodules using support vector machine model based on 2-[18F]fluoro-2-deoxy-D-glucose PET/computed tomography texture features.
    Nucl Med Commun. 2020 Apr 10. doi: 10.1097/MNM.0000000000001193.
    PubMed     Abstract available


  183. FRAIOLI F, Shankar A, Hyare H, Ferrazzoli V, et al
    The use of multiparametric 18F-fluoro-L-3,4-dihydroxy-phenylalanine PET/MRI in post-therapy assessment of patients with gliomas.
    Nucl Med Commun. 2020 Apr 10. doi: 10.1097/MNM.0000000000001184.
    PubMed     Abstract available


  184. KIM DH, Kim SJ
    Diagnostic performances of F-18 FDG PET or PET/CT for detection of post-transplant lymphoproliferative disorder: a systematic review and meta-analysis.
    Nucl Med Commun. 2020 Apr 10. doi: 10.1097/MNM.0000000000001194.
    PubMed     Abstract available


  185. SHAO X, Chen Y, Shao X, Wang S, et al
    Gender differences in brown adipose tissue-related brain functional networks: an 18F-FDG-PET study.
    Nucl Med Commun. 2020 Apr 10. doi: 10.1097/MNM.0000000000001190.
    PubMed     Abstract available


  186. HUANG HL, Allie R, Gnanasegaran G, Bomanji J, et al
    COVID19 -Nuclear Medicine Departments, be prepared!
    Nucl Med Commun. 2020;41:297-299.
    PubMed    


  187. TALAAT OM, Ali IM, Abolyazid SM, Abdelmaksoud B, et al
    Long-term scintigraphic and clinical follow up in patients with differentiated thyroid cancer and iodine avid bone metastases.
    Nucl Med Commun. 2020;41:327-335.
    PubMed     Abstract available


  188. CHEN YC, Han DY, Chang CC, Su CH, et al
    The establishment and application of sialoscintigraphic reference values from patients with obstructive sialadenitis.
    Nucl Med Commun. 2020;41:308-313.
    PubMed     Abstract available


  189. WANG L, Wu Z, Wang A, Jin X, et al
    Effects of nucleo(s)tide analogs therapy on chronic hepatitis B as evaluated by hepatosplenic radionuclide angiography.
    Nucl Med Commun. 2020;41:314-319.
    PubMed     Abstract available


    March 2020
  190. KUPIK O, Akin S, Tuncel M, Eren G, et al
    Comparison of clinical and PET-derived prognostic factors in patients with non-Hodgkin lymphoma: a special emphasis on bone marrow involvement.
    Nucl Med Commun. 2020 Mar 23. doi: 10.1097/MNM.0000000000001182.
    PubMed     Abstract available


  191. SHI YM, Niu R, Shao XL, Zhang FF, et al
    Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
    Nucl Med Commun. 2020 Mar 13. doi: 10.1097/MNM.0000000000001173.
    PubMed     Abstract available


  192. UEDA CE, Duarte PS, de Castroneves LA, Marin JFG, et al
    Burden of metastatic bone disease measured on 18F-NaF PET/computed tomography studies as a prognostic indicator in patients with medullary thyroid cancer.
    Nucl Med Commun. 2020 Mar 13. doi: 10.1097/MNM.0000000000001175.
    PubMed     Abstract available


  193. KITAJIMA K, Kaida H, Nakatani K, Ishibashi M, et al
    Assessment of tumor response to definitive chemoradiotherapy and prognosis prediction in patients with esophageal cancer judged by PET response criteria in solid tumors: multicenter study in Japan.
    Nucl Med Commun. 2020 Mar 13. doi: 10.1097/MNM.0000000000001168.
    PubMed     Abstract available


  194. RIBEIRO ASF, Husson O, Drey N, Murray I, et al
    Radiation exposure awareness from patients undergoing nuclear medicine diagnostic 99mTc-MDP bone scans and 2-deoxy-2-(18F) fluoro-D-glucose PET/computed tomography scans.
    Nucl Med Commun. 2020 Mar 13. doi: 10.1097/MNM.0000000000001177.
    PubMed     Abstract available


  195. YANG S, Fu L, AbuduRxiti M, Wu J, et al
    Application of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in mantle cell lymphoma.
    Nucl Med Commun. 2020 Mar 2. doi: 10.1097/MNM.0000000000001170.
    PubMed     Abstract available


  196. HODOLIC M, Ambrosini V, Fanti S
    Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer.
    Nucl Med Commun. 2020 Mar 2. doi: 10.1097/MNM.0000000000001172.
    PubMed     Abstract available


  197. SINGH H, Arora G, Nayak B, Sharma A, et al
    Semi-quantitative F-18-FDG PET/computed tomography parameters for prediction of grade in patients with renal cell carcinoma and the incremental value of diuretics.
    Nucl Med Commun. 2020 Mar 2. doi: 10.1097/MNM.0000000000001169.
    PubMed     Abstract available



  198. Harmonization of standardized uptake values between two scanners, considering repeatability and magnitude of the values in clinical fluorine-18-fluorodeoxyglucose PET settings: a phantom study: Erratum.
    Nucl Med Commun. 2020;41:296.
    PubMed    


  199. GULTEKIN A
    Calculation of interobserver agreement in Ga68 PSMA-PET/CT: weighted kappa.
    Nucl Med Commun. 2020;41:295.
    PubMed    


  200. SABOUR S
    Agreement for the interpretation of 68Ga-prostate-specific membrane antigen-I&T positron emission tomography/computed tomography imaging; methodological issues to avoid misinterpretation.
    Nucl Med Commun. 2020;41:294.
    PubMed    


  201. HU B, Xiao J, Xiu Y, Fu Z, et al
    Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically resected pulmonary adenocarcinoma.
    Nucl Med Commun. 2020;41:252-259.
    PubMed     Abstract available


  202. GUPTA A, Patel C, Gupta SK, Ramakrishnan S, et al
    Myocardial perfusion abnormalities in Eisenmenger syndrome.
    Nucl Med Commun. 2020;41:206-211.
    PubMed     Abstract available


  203. POURHASSAN SHAMCHI S, Zirakchian Zadeh M, Ostergaard B, Kim J, et al
    Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation.
    Nucl Med Commun. 2020;41:288-293.
    PubMed     Abstract available


  204. ITO T, Onoguchi M, Okuda K, Shibutani T, et al
    Study of novel deformable image registration in myocardial perfusion single-photon emission computed tomography.
    Nucl Med Commun. 2020;41:196-205.
    PubMed     Abstract available


  205. BHURE U, Roos JE, Perez-Lago MDS, Strobel K, et al
    Single-photon emission computed tomography/computed tomography arthrography of wrist, ankle, and knee joints.
    Nucl Med Commun. 2020;41:182-188.
    PubMed     Abstract available


    February 2020
  206. GUPTA N, Singh N
    To evaluate prognostic significance of metabolic-derived tumour volume at staging 18-flurodeoxyglucose PET-CT scan and to compare it with standardized uptake value-based response evaluation on interim 18-flurodeoxyglucose PET-CT scan in patients of no
    Nucl Med Commun. 2020 Feb 15. doi: 10.1097/MNM.0000000000001159.
    PubMed     Abstract available


  207. NANASHIMA A, Hiyoshi M, Imamura N, Yano K, et al
    Validation set analysis to predict postoperative outcomes by technetium-99m galactosyl serum albumin scintigraphy for hepatectomy.
    Nucl Med Commun. 2020 Feb 15. doi: 10.1097/MNM.0000000000001162.
    PubMed     Abstract available


  208. TAKAHASHI MES, Mosci C, Souza EM, Brunetto SQ, et al
    Computed tomography-based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma.
    Nucl Med Commun. 2020 Feb 12. doi: 10.1097/MNM.0000000000001165.
    PubMed     Abstract available


  209. LIAN W, Liu C, Gu B, Zhang J, et al
    The early prediction of pathological response to neoadjuvant chemotherapy and prognosis: comparison of PET Response Criteria in Solid Tumors and European Organization for Research and Treatment of Cancer criteria in breast cancer.
    Nucl Med Commun. 2020 Feb 4. doi: 10.1097/MNM.0000000000001145.
    PubMed     Abstract available


  210. ZHAO J, Wang H, Li Q
    Value of 18F-FDG PET/computed tomography in predicting the simplified WHO grade of malignancy in thymic epithelial tumors.
    Nucl Med Commun. 2020 Feb 4. doi: 10.1097/MNM.0000000000001158.
    PubMed     Abstract available


  211. PINTO-LEITE T, Tixier F, Upadhaya T, Gallais C, et al
    Qualitative and quantitative reproducibility of [18]fluoromethycholine PET/computed tomography in prostate cancer.
    Nucl Med Commun. 2020;41:147-154.
    PubMed     Abstract available


  212. RADULOVIC M, Jankovic MM, Durutovic O, Sobic-Saranovic DP, et al
    Interobserver reproducibility of mercaptoacetyltriglicine renography in children and adults with suspected obstruction: parameters of drainage and function calculated by International Atomic Energy Agency software.
    Nucl Med Commun. 2020;41:96-103.
    PubMed     Abstract available


  213. CHIARAVALLOTI A, Barbagallo G, Castellano AE, Ricci M, et al
    [18F] FBB cortical uptake is not related to the age of onset of Alzheimer's disease.
    Nucl Med Commun. 2020;41:175-180.
    PubMed     Abstract available


  214. OLIVEIRA-SANTOS M, McMahon G, Castelo-Branco M, Silva R, et al
    Renal artery wall 18F-NaF activity and glomerular filtration rate: an exploratory analysis in a high cardiovascular risk population.
    Nucl Med Commun. 2020;41:126-132.
    PubMed     Abstract available


  215. JUWEID ME, Omari Y, Khawaja N, AlSharif A, et al
    Use of pinhole dual-phase Tc-99m sestamibi vs combined Tc-99m sestamibi and Tc-99m pertechnetate scintigraphy in patients with hyperparathyroidism where single-photon emission computed tomography/computed tomography is unavailable.
    Nucl Med Commun. 2020;41:87-95.
    PubMed     Abstract available


    January 2020
  216. JIANG Y, Hou G, Cheng W
    Performance of 68Ga-DOTA-SST PET/CT, octreoscan SPECT/CT and 18F-FDG PET/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis.
    Nucl Med Commun. 2020 Jan 28. doi: 10.1097/MNM.0000000000001163.
    PubMed     Abstract available


  217. WEBER M, Kessler L, Schaarschmidt B, Fendler WP, et al
    Textural analysis of hybrid DOTATOC-PET/MRI and its association with histological grading in patients with liver metastases from neuroendocrine tumors.
    Nucl Med Commun. 2020 Jan 21. doi: 10.1097/MNM.0000000000001150.
    PubMed     Abstract available


  218. TASKIN S, Varli B, Ersoz CC, Altin D, et al
    Complementary role of 18F-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis.
    Nucl Med Commun. 2020 Jan 13. doi: 10.1097/MNM.0000000000001157.
    PubMed     Abstract available


  219. NATH A, Prashanth A, Lal H, Kumar S, et al
    Robotic-assisted computed tomography-guided 18F-FDG PET/computed tomography-directed biopsy for diagnosis of intra thoracic lesions: An experience from a tertiary care centre in North India.
    Nucl Med Commun. 2020 Jan 13. doi: 10.1097/MNM.0000000000001148.
    PubMed     Abstract available


  220. PURANDARE NC, Puranik A, Shah S, Agrawal A, et al
    Differentiating dural metastases from meningioma: role of 68Ga DOTA-NOC PET/CT.
    Nucl Med Commun. 2020 Jan 13. doi: 10.1097/MNM.0000000000001155.
    PubMed     Abstract available


  221. KIKO T, Yoshihisa A, Yokokawa T, Misaka T, et al
    Direct comparisons of left ventricular volume and function by simultaneous cardiac magnetic resonance imaging and gated 13N-ammonia positron emission tomography.
    Nucl Med Commun. 2020 Jan 13. doi: 10.1097/MNM.0000000000001149.
    PubMed     Abstract available


  222. ORDIDGE KL, Gandy N, Arshad MA, Wallitt K, et al
    Interobserver agreement of the visual Herder scale for the assessment of solitary pulmonary nodules on 18F Fluorodeoxyglucose PET/computed tomography.
    Nucl Med Commun. 2020 Jan 8. doi: 10.1097/MNM.0000000000001146.
    PubMed     Abstract available


  223. SHINYA T, Otomi Y, Dimitrakopoulou-Strauss A, Kubo M, et al
    Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for evaluating the clinicopathological grade in patients with non-Hodgkin's lymphoma: a prospective study.
    Nucl Med Commun. 2020;41:26-33.
    PubMed     Abstract available


  224. RIYAMI KA, Nuaimi NA, Kliokyte R, Voo S, et al
    Revalidation of PET/computed tomography criteria (Hopkins criteria) for the assessment of therapeutic response in lung cancer patients: inter-reader reliability, accuracy and survival outcomes.
    Nucl Med Commun. 2020;41:18-25.
    PubMed     Abstract available


  225. FILIPPI L, Di Costanzo GG, Tortora R, Pelle G, et al
    Prognostic value of neutrophil-to-lymphocyte ratio and its correlation with fluorine-18-fluorodeoxyglucose metabolic parameters in intrahepatic cholangiocarcinoma submitted to 90Y-radioembolization.
    Nucl Med Commun. 2020;41:78-86.
    PubMed     Abstract available


    December 2019
  226. RIAZ S, Syed R, Aziz TA, Alnaim A, et al
    The value of 18F-FDG PET-CT and 131I-norcholesterol scintigraphy in the characterization of high-risk adrenal masses.
    Nucl Med Commun. 2019 Dec 31. doi: 10.1097/MNM.0000000000001142.
    PubMed     Abstract available


  227. KANDEEL AA, Hussein M, Zidan L, Younis J, et al
    Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
    Nucl Med Commun. 2019 Dec 31. doi: 10.1097/MNM.0000000000001139.
    PubMed     Abstract available


  228. PINTO-LEITE T, Tixier F, Upadhaya T, Gallais C, et al
    Qualitative and quantitative reproducibility of [18]fluoromethycholine PET/computed tomography in prostate cancer.
    Nucl Med Commun. 2019 Dec 24. doi: 10.1097/MNM.0000000000001129.
    PubMed     Abstract available


  229. ARSLAN E, Aksoy T, Can Trabulus FD, Kelten Talu C, et al
    The association of 18F-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin alphavbeta3 receptor levels in patients with breast cancer.
    Nucl Med Commun. 2019 Dec 24. doi: 10.1097/MNM.0000000000001133.
    PubMed     Abstract available


  230. SKOURA E, Priftakis D, Novruzov F, Caplin ME, et al
    The impact of Ga-68 DOTATATE PET/CT imaging on management of patients with paragangliomas.
    Nucl Med Commun. 2019 Dec 24. doi: 10.1097/MNM.0000000000001130.
    PubMed     Abstract available


  231. KOTHEKAR E, Yellanki D, Borja AJ, Al-Zaghal A, et al
    18F-FDG-PET/CT in measuring volume and global metabolic activity of thigh muscles: a novel CT-based tissue segmentation methodology.
    Nucl Med Commun. 2019 Dec 19. doi: 10.1097/MNM.0000000000001127.
    PubMed     Abstract available


  232. KAMASAKI T, Mori K, Taira Y, Orita M, et al
    PET/computed tomography shows association between subjective pain in knee joints and fluorine-18-fluorodeoxyglucose uptake.
    Nucl Med Commun. 2019 Dec 13. doi: 10.1097/MNM.0000000000001143.
    PubMed     Abstract available


  233. HAODAN D, Ruimin W, Jiajin L, Mu L, et al
    Positron emission tomography/magnetic resonance imaging for the diagnosis and differentiation of pancreatic tumors.
    Nucl Med Commun. 2019 Dec 11. doi: 10.1097/MNM.0000000000001125.
    PubMed     Abstract available


  234. GUPTA P, Murthy V, Agarwal A, Maitre M, et al
    68Ga-prostate-specific membrane antigen PETCT-based response to androgen deprivation therapy in patients with prostate cancer.
    Nucl Med Commun. 2019;40:1283-1288.
    PubMed     Abstract available


  235. OKUDAN B, Seven B, Coskun N, Albayrak A, et al
    Comparison between single-photon emission computed tomography/computed tomography and ultrasound in preoperative detection of parathyroid adenoma: retrospective review of an institutional experience.
    Nucl Med Commun. 2019;40:1211-1215.
    PubMed     Abstract available


  236. GUPTA V, Verma R, Ranjan R, Belho ES, et al
    Metabolic imaging patterns in posterior cortical atrophy and Lewy body dementia.
    Nucl Med Commun. 2019;40:1275-1282.
    PubMed     Abstract available


  237. KIM H, Oh M, Oh JS, Moon H, et al
    Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
    Nucl Med Commun. 2019;40:1216-1223.
    PubMed     Abstract available


    November 2019
  238. KAIDA H, Azuma K, Kawahara A, Takamori S, et al
    Prognostic value of dual-point fluorine-18 fluorodeoxyglucose PET imaging, partial volume correction and glucose transporter-1 expression in resected nonsmall cell lung cancer patients.
    Nucl Med Commun. 2019 Nov 19. doi: 10.1097/MNM.0000000000001118.
    PubMed     Abstract available


  239. RYOO HG, Paeng JC, Koo BK, Cheon GJ, et al
    Clinical implication of 18F-NaF PET/computed tomography indexes of aortic calcification in coronary artery disease patients: correlations with cardiovascular risk factors.
    Nucl Med Commun. 2019 Nov 15. doi: 10.1097/MNM.0000000000001115.
    PubMed     Abstract available


  240. SHACHAR B, Prica A, Anconina R, Hawsawy A, et al
    Impact of 18F-fluorodeoxyglucose PET/CT in the management of patients with plasma cell disorders.
    Nucl Med Commun. 2019 Nov 15. doi: 10.1097/MNM.0000000000001113.
    PubMed     Abstract available


  241. BOER JJ, Kappelhof JJJS, van der Zant FM, Wondergem M, et al
    13N-ammonia PET/CT stress myocardial blood flow compared to fractional flow reserve in coronary artery disease.
    Nucl Med Commun. 2019 Nov 15. doi: 10.1097/MNM.0000000000001117.
    PubMed     Abstract available


  242. LING X, Chen J, Shang J, Tang Y, et al
    Sequential PET/diffusion-weighted imaging in the evaluation of myocardial perfusion and viability in coronary artery disease: a preliminary study.
    Nucl Med Commun. 2019 Nov 15. doi: 10.1097/MNM.0000000000001109.
    PubMed     Abstract available


  243. KULKARNI SC, Sundaram PS, Padma S
    In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen PET computed tomography?
    Nucl Med Commun. 2019 Nov 7. doi: 10.1097/MNM.0000000000001110.
    PubMed     Abstract available


  244. RAMOS CD, Onusic DM, Brunetto SQ, Amorim BJ, et al
    Technetium-99m-dimercaptosuccinic acid renal scintigraphy and single photon emission computed tomography/computed tomography in patients with sickle cell disease.
    Nucl Med Commun. 2019;40:1158-1165.
    PubMed     Abstract available


  245. LOPCI E, Novellis P, Testori A, Rahal D, et al
    In-vivo imaging of methionine metabolism in patients with suspected malignant pleural mesothelioma.
    Nucl Med Commun. 2019;40:1179-1186.
    PubMed     Abstract available


  246. OZDE C, Akture G, Aytekin S, Sayin AE, et al
    Assessment of the relationship between coronary flow rates and myocardial perfusion abnormality in patients with nonobstructive coronary artery disease: an observational study in cardiac syndrome X and coronary slow flow.
    Nucl Med Commun. 2019;40:1122-1129.
    PubMed     Abstract available


  247. OKIZAKI A, Yamamoto W, Saito W, Miyano T, et al
    An investigation of asymmetric reduction in dopamine transporter density in patients with Parkinson's disease.
    Nucl Med Commun. 2019;40:1187-1192.
    PubMed     Abstract available


  248. SUNDARAM PS, Subramanyam P
    Effectiveness of sentinel lymph node scintigraphy and intraoperative gamma probing with gold standard elective neck dissection in patients with N0 oral squamous cell cancers.
    Nucl Med Commun. 2019;40:1138-1147.
    PubMed     Abstract available


  249. YAMADA Y, Nakano S, Gatate Y, Sugi K, et al
    Shortened acquisition time in simultaneous 99mTc-tetrofosmin and 123I-beta-methyl-p-iodophenyl pentadecanoic acid dual-tracer imaging with cadmium-zinc-telluride detectors in patients undergoing primary coronary intervention for acute myocardial infar
    Nucl Med Commun. 2019;40:1130-1137.
    PubMed     Abstract available


  250. WANG C, Dong X, Sun X, Zhang R, et al
    Association of radiomic features with epidermal growth factor receptor mutation status in non-small cell lung cancer and survival treated with tyrosine kinase inhibitors.
    Nucl Med Commun. 2019;40:1091-1098.
    PubMed     Abstract available


    October 2019
  251. SOYDAL C, Nak D, Araz M, Akkus P, et al
    Comparison of bone scintigraphy and Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography in the detection of bone metastases of prostate carcinoma.
    Nucl Med Commun. 2019 Oct 28. doi: 10.1097/MNM.0000000000001106.
    PubMed     Abstract available


  252. ARORA S, Kumar R, Passah A, Tripathi M, et al
    Prospective evaluation of 68Ga-DOTANOC positron emission tomography/computed tomography and 131I-meta-iodobenzylguanidine single-photon emission computed tomography/computed tomography in extra-adrenal paragangliomas, including uncommon primary sites
    Nucl Med Commun. 2019 Oct 15. doi: 10.1097/MNM.0000000000001096.
    PubMed     Abstract available


  253. GULTEKIN A, Yaylali O, Sengoz T, Yuksel D, et al
    Intraobserver and interobserver agreement for the interpretation of 68Ga-prostate-specific membrane antigen-I&T positron emission tomography/computed tomography imaging.
    Nucl Med Commun. 2019 Oct 2. doi: 10.1097/MNM.0000000000001097.
    PubMed     Abstract available


  254. CORRALES-MEDINA VF, Habibi CM, Wang J, Glassman SJ, et al
    A novel method to measure vascular inflammation by [18F]fluorodeoxyglucose PET/computed tomography scanning of the aorta.
    Nucl Med Commun. 2019;40:1087-1089.
    PubMed    


  255. MARQUES DE SOUZA FILHO E, Tinoco Mesquita C, Altenburg Gismondi R, de Amorim Fernandes F, et al
    Are there normal values of phase analysis parameters for left ventricular dyssynchrony in patients with no structural cardiomyopathy?: a systematic review.
    Nucl Med Commun. 2019;40:980-985.
    PubMed     Abstract available


  256. WU J, Wang Q, Zhao Q, Li L, et al
    Research on the method of controlling the 99mTc-Technegas inhaled during 1-day pulmonary ventilation/perfusion imaging.
    Nucl Med Commun. 2019;40:995-1000.
    PubMed     Abstract available


  257. LI Y, Xu J, Xu X, Zhang J, et al
    Long-acting octreotide treatment has no impact on tumor uptake of 99mTc-HYNIC-TOC in patients with neuroendocrine tumors.
    Nucl Med Commun. 2019;40:1005-1010.
    PubMed     Abstract available


  258. WERNER RA, Lapa C, Sheikhbahaei S, Marcus C, et al
    Impact of aging on semiquantitative uptake parameters in normal rated clinical baseline [123I]Ioflupane single photon emission computed tomography/computed tomography.
    Nucl Med Commun. 2019;40:1001-1004.
    PubMed     Abstract available


    September 2019
  259. SIMINIAK N, Wojciechowska K, Miechowicz I, Cholewinski W, et al
    18F-choline positron emission tomography/computed tomography for the detection of prostate cancer relapse: assessment of maximum standardized uptake value correlation with prostate-specific antigen levels.
    Nucl Med Commun. 2019 Sep 26. doi: 10.1097/MNM.0000000000001095.
    PubMed     Abstract available


  260. ERDOGAN M, Erdemoglu E, Evrimler S, Hanedan C, et al
    Prognostic value of metabolic tumor volume and total lesion glycolysis assessed by 18F-FDG PET/CT in endometrial cancer.
    Nucl Med Commun. 2019 Sep 16. doi: 10.1097/MNM.0000000000001091.
    PubMed     Abstract available


  261. SHAO X, Shao X, Niu R, Xing W, et al
    A simple prediction model using fluorodeoxyglucose-PET and high-resolution computed tomography for discrimination of invasive adenocarcinomas among solitary pulmonary ground-glass opacity nodules.
    Nucl Med Commun. 2019 Sep 16. doi: 10.1097/MNM.0000000000001092.
    PubMed     Abstract available


  262. SOYDAL C, Araz M, Urun Y, Gulpinar B, et al
    18F-Flourodeoxy glucose PET-computed tomography in testicular carcinoma: diagnostic and prognostic value.
    Nucl Med Commun. 2019 Sep 16. doi: 10.1097/MNM.0000000000001093.
    PubMed     Abstract available


  263. PARK SY, Barrato L, Hatami N, Davidzon G, et al
    Initial experience with a PET/computed tomography system using silicon photomultiplier detectors.
    Nucl Med Commun. 2019 Sep 16. doi: 10.1097/MNM.0000000000001088.
    PubMed     Abstract available


  264. ISIKCI NI, Abuqbeitah M, Gunay O, Yeyin N, et al
    Comparison between planar, SPECT and SPECT/computed tomography systems in 99mTc- nanocolloid sentinel lymph node imaging: phantom design and clinical investigations. Erratum.
    Nucl Med Commun. 2019;40:973.
    PubMed    


  265. REDMAN S, Graham R, Little D
    Parathyroid scintigraphy.
    Nucl Med Commun. 2019;40:e1-e3.
    PubMed     Abstract available


  266. BHOIL A, Caw H, Vinjamuri S
    Role of 18F-flurodeoxyglucose in orthopaedic implant-related infection: review of literature and experience.
    Nucl Med Commun. 2019;40:875-887.
    PubMed     Abstract available


  267. WU H, Zhao X, Ting Kung B, Sing Ng K, et al
    Effect of nasogastric tube on salivagram result in paediatric patients.
    Nucl Med Commun. 2019;40:894-897.
    PubMed     Abstract available


    August 2019
  268. AMAKUSA S, Matsuoka K, Baba S, Yoshida T, et al
    Differences in edge artifacts between 68Ga- and 18F-PET images reconstructed using point spread function correction.
    Nucl Med Commun. 2019 Aug 28. doi: 10.1097/MNM.0000000000001079.
    PubMed     Abstract available


  269. YILMAZ B, Dag S, Ergul N, Cermik TF, et al
    The ability of pre-treatment F-18 FDG PET/CT metabolic parameters for predicting axillary lymph node and distant metastasis and overall survival.
    Nucl Med Commun. 2019 Aug 28. doi: 10.1097/MNM.0000000000001085.
    PubMed     Abstract available


  270. BIALEK EJ, Malkowski B
    Are superior cervical sympathetic ganglia avid on whole body 68Ga-PSMA-11 PET/magnetic resonance?: a comprehensive morphologic and molecular assessment in patients with prostate cancer.
    Nucl Med Commun. 2019 Aug 28. doi: 10.1097/MNM.0000000000001083.
    PubMed     Abstract available


  271. OZKAN EE, Sengul SS, Erdogan M, Gurdal O, et al
    18F-fluorodeoxyglucose PET/computed tomography in locoregional staging and assessment of biological and clinical aggressiveness of breast cancer subtypes.
    Nucl Med Commun. 2019 Aug 12. doi: 10.1097/MNM.0000000000001073.
    PubMed     Abstract available


  272. OWAKI Y, Nakahara T, Shimizu T, Smith AM, et al
    Response to: Effects of breathing motion on PET acquisitions: step and shoot versus continuous bed motion.
    Nucl Med Commun. 2019;40:873-874.
    PubMed    


  273. PURI T, Blake G
    Effects of breathing motion on PET acquisitions: step and shoot versus continuous bed motion.
    Nucl Med Commun. 2019;40:873.
    PubMed    


  274. JIANG M, Zhang Y, Xu J, Ji M, et al
    Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET/CT.
    Nucl Med Commun. 2019;40:842-849.
    PubMed     Abstract available


  275. ISIKCI NI
    Comparison between planar, SPECT and SPECT/computed tomography systems in 99mTc- nanocolloid sentinel lymph node imaging: phantom design and clinical investigations.
    Nucl Med Commun. 2019;40:786-791.
    PubMed     Abstract available


  276. PRICE E, Tipping J, Cullen DM, Calvert N, et al
    Positional dependence of activity determination in single photon emission computed tomography.
    Nucl Med Commun. 2019;40:865-872.
    PubMed     Abstract available


  277. SHIRAKAWA S, Tsukamoto K, Azuma H, Nakashima K, et al
    Nonuniform sampling pitch acquisition method in myocardial single-photon emission computed tomography.
    Nucl Med Commun. 2019;40:792-801.
    PubMed     Abstract available


  278. SONMEZER B, Acar E, Erkoyun E, Capa Kaya G, et al
    Does lymph node localization affect prostate-specific membrane antigen uptake?
    Nucl Med Commun. 2019;40:835-841.
    PubMed     Abstract available


    July 2019
  279. MORI M, Fujioka T, Katsuta L, Tsuchiya J, et al
    Diagnostic performance of time-of-flight PET/CT for evaluating nodal metastasis of the axilla in breast cancer.
    Nucl Med Commun. 2019 Jul 29. doi: 10.1097/MNM.0000000000001057.
    PubMed     Abstract available


  280. KIM SJ, Ryul Shim S
    Diagnostic value of radiolabeled amino acid PET for detection of pseudoprogression of brain tumor after treatment: a meta-analysis.
    Nucl Med Commun. 2019 Jul 29. doi: 10.1097/MNM.0000000000001060.
    PubMed     Abstract available


  281. MOYADE P, Vinjamuri S
    The heart matters: a review of incidental cardiac uptake on Ga-68 DOTA peptide PET-CT scans.
    Nucl Med Commun. 2019 Jul 29. doi: 10.1097/MNM.0000000000001064.
    PubMed     Abstract available


  282. INCERTI E, Vanoli EG, Broggi S, Gumina C, et al
    Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients.
    Nucl Med Commun. 2019 Jul 29. doi: 10.1097/MNM.0000000000001065.
    PubMed     Abstract available


  283. AFAQ A, Ell PJ, Bomanji JB
    Is it time to fund routine NHS usage of PSMA PET-CT?
    Nucl Med Commun. 2019 Jul 29. doi: 10.1097/MNM.0000000000001066.
    PubMed    


  284. CAN C, Komek H
    Metabolic and volume-based parameters of (18F)FDG PET/CT for primary mass and axillary lymph node metastasis in patients with invasive ductal carcinoma: a retrospective analysis in relation to molecular subtype, axillary lymph node metastasis and immu
    Nucl Med Commun. 2019 Jul 29. doi: 10.1097/MNM.0000000000001074.
    PubMed     Abstract available


  285. FUJIKURA M, Nakamura S, Asai S, Kurabayashi T, et al
    Diagnostic ability of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography for retropharyngeal lymph node in patients with oral cancer.
    Nucl Med Commun. 2019 Jul 29. doi: 10.1097/MNM.0000000000001071.
    PubMed     Abstract available


  286. BASU S, Adnan A
    Well-differentiated grade 3 neuroendocrine tumours and poorly differentiated grade 3 neuroendocrine carcinomas: will dual tracer PET-computed tomography (68Ga-DOTATATE and FDG) play a pivotal role in differentiation and guiding management strategies?
    Nucl Med Commun. 2019 Jul 29. doi: 10.1097/MNM.0000000000001072.
    PubMed    


  287. ALONGI P, Laudicella R, Gentile R, Scalisi S, et al
    Potential clinical value of quantitative fluorine-18-fluorodeoxyglucose-PET/computed tomography using a graph-based method analysis in evaluation of incidental lesions of gastrointestinal tract: correlation with endoscopic and histopathological findin
    Nucl Med Commun. 2019 Jul 29. doi: 10.1097/MNM.0000000000001062.
    PubMed     Abstract available


  288. COURA-FILHO GB, Hoff AAFO, Duarte PS, Buchpiguel CA, et al
    68Ga-DOTATATE PET: temporal variation of maximum standardized uptake value in normal tissues and neuroendocrine tumours.
    Nucl Med Commun. 2019 Jul 22. doi: 10.1097/MNM.0000000000001048.
    PubMed     Abstract available


  289. CHEN B, Wei P, Macapinlac HA, Lu Y, et al
    Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer.
    Nucl Med Commun. 2019 Jul 22. doi: 10.1097/MNM.0000000000001051.
    PubMed     Abstract available


  290. DAVIDSON T, Amit U, Saad A, Hahiashvili M, et al
    Gallium-68 prostate-specific membrane antigen PET-CT and the clinical management of prostate cancer.
    Nucl Med Commun. 2019 Jul 22. doi: 10.1097/MNM.0000000000001047.
    PubMed     Abstract available


  291. DICKSON JC
    Quantitative SPECT: a survey of current practice in the UK Nuclear Medicine Community.
    Nucl Med Commun. 2019 Jul 22. doi: 10.1097/MNM.0000000000001059.
    PubMed     Abstract available


  292. XU M, Wang L, Ouyang M, Lin J, et al
    Prediction of lymph node metastasis by PET/CT metabolic parameters in patients with esophageal squamous cell carcinoma.
    Nucl Med Commun. 2019 Jul 22. doi: 10.1097/MNM.0000000000001050.
    PubMed     Abstract available


  293. LI R, Lin J, Wang L, Zheng X, et al
    The association between 18F-fluorodeoxyglucose PET intratumoral metabolic heterogeneity and pathological parameters in non-small cell lung cancer.
    Nucl Med Commun. 2019 Jul 22. doi: 10.1097/MNM.0000000000001058.
    PubMed     Abstract available


  294. ZHENG Y, Yuan H, Li Y, Wang C, et al
    The quantitative carbohydrate ingestion ratio for extensive skeletal muscle uptake in 18F-FDG PET/computed tomography.
    Nucl Med Commun. 2019 Jul 22. doi: 10.1097/MNM.0000000000001053.
    PubMed     Abstract available


  295. SPYRIDONIDIS T, Spyridonidis J, Papathanasiou N, Katsanos K, et al
    History and development of radioembolization: an old idea with modern applications.
    Nucl Med Commun. 2019;40:684-692.
    PubMed     Abstract available


  296. KERAMIDA G, Gregg S, Peters AM
    Intrahepatic fluorine-18-fluorodeoxyglucose kinetics measured by least squares nonlinear computer modelling and Gjedde-Patlak-Rutland graphical analysis.
    Nucl Med Commun. 2019;40:675-683.
    PubMed     Abstract available


  297. DRIESSEN RS, Raijmakers PG, Danad I, Stuijfzand WJ, et al
    Adenosine single-photon emission computed tomography-derived transient ischemic dilatation and ejection fraction reserve fail to predict multivessel coronary artery disease.
    Nucl Med Commun. 2019;40:773-774.
    PubMed     Abstract available


  298. ITO T, Onoguchi M, Ogata Y, Matsusaka Y, et al
    Evaluation of edge-preserving and noise-reducing effects using the nonlinear diffusion method in bone single-photon emission computed tomography.
    Nucl Med Commun. 2019;40:693-702.
    PubMed     Abstract available


  299. ROBERTS G, Kane JPM, Lloyd JJ, Petrides GS, et al
    A comparison of visual and semiquantitative analysis methods for planar cardiac 123I-MIBG scintigraphy in dementia with Lewy bodies.
    Nucl Med Commun. 2019;40:734-743.
    PubMed     Abstract available


  300. NAKASHIMA M, Shinya T, Oto T, Okawa T, et al
    Diagnostic value of ventilation/perfusion single-photon emission computed tomography/computed tomography for bronchiolitis obliterans syndrome in patients after lung transplantation.
    Nucl Med Commun. 2019;40:703-710.
    PubMed     Abstract available


  301. RASSAM F, Uz Z, van Lienden KP, Ince C, et al
    Quantitative assessment of liver function using hepatobiliary scintigraphy: the effect of microcirculatory alterations after portal vein embolization.
    Nucl Med Commun. 2019;40:720-726.
    PubMed     Abstract available


    June 2019
  302. MAENO N
    Correlation between beta-amyloid deposits revealed by BF-227-PET imaging and brain atrophy detected by voxel-based morphometry-MR imaging: a pilot study.
    Nucl Med Commun. 2019 Jun 25. doi: 10.1097/MNM.0000000000001042.
    PubMed     Abstract available


  303. PEERLINGS J, Paulis L, Mitea C, Bakers F, et al
    Performing clinical 18F-FDG-PET/MRI of the mediastinum optimising a dedicated, patient-friendly protocol.
    Nucl Med Commun. 2019 Jun 4. doi: 10.1097/MNM.0000000000001035.
    PubMed     Abstract available


  304. HSU CC, Ho KW, Chang YH, Huang YC, et al
    Combining fluorine-18 fluorodeoxyglucose positron emission tomography and pathological risk factors to predict postoperative recurrence in stage I lung adenocarcinoma.
    Nucl Med Commun. 2019;40:632-638.
    PubMed     Abstract available


  305. RICE SR, Saboury B, Houshmand S, Salavati A, et al
    Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy.
    Nucl Med Commun. 2019;40:618-625.
    PubMed     Abstract available


  306. WU MH, Liu FH, Lin KJ, Sun JH, et al
    Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan.
    Nucl Med Commun. 2019;40:568-575.
    PubMed     Abstract available


    May 2019
  307. IIZUKA H, Daisaki H, Ogawa M, Yoshida K, et al
    Harmonization of standardized uptake values between two scanners, considering repeatability and magnitude of the values in clinical fluorine-18-fluorodeoxyglucose PET settings: a phantom study.
    Nucl Med Commun. 2019 May 28. doi: 10.1097/MNM.0000000000001037.
    PubMed     Abstract available


  308. AFAQ A, Gleeson F, Scarsbrook A, Bradley K, et al
    UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging.
    Nucl Med Commun. 2019 May 27. doi: 10.1097/MNM.0000000000001030.
    PubMed     Abstract available


  309. EL-KHOLY E, El Nadi E, Hafez H, Ahmed S, et al
    Added predictive value of 18F-FDG PET/CT for pediatric rhabdomyosarcoma.
    Nucl Med Commun. 2019 May 27. doi: 10.1097/MNM.0000000000001040.
    PubMed     Abstract available


  310. QUARTUCCIO N, Evangelista L, Alongi P, Caobelli F, et al
    Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study.
    Nucl Med Commun. 2019 May 24. doi: 10.1097/MNM.0000000000001038.
    PubMed     Abstract available


  311. YU P, Ning J, Xu B, Liu J, et al
    Histogram analysis of 11C-methionine integrated PET/MRI may facilitate to determine the O6-methylguanylmethyltransferase methylation status in gliomas.
    Nucl Med Commun. 2019 May 22. doi: 10.1097/MNM.0000000000001039.
    PubMed     Abstract available


  312. SONG Q, Long L, Cui S, Shu H, et al
    Utility of technetium-99m-methylene diphosphonate single-photon emission computed tomography/computed tomography fusion in detecting post-traumatic chronic-infected nonunion in the lower limb.
    Nucl Med Commun. 2019 May 20. doi: 10.1097/MNM.0000000000001027.
    PubMed     Abstract available


  313. SOFFER S, Amitai MM, Weizen R, Retter A, et al
    PET-CT imaging features that differentiate between positive and negative EWSR1 translocation in Ewing sarcoma.
    Nucl Med Commun. 2019 May 17. doi: 10.1097/MNM.0000000000001031.
    PubMed     Abstract available


  314. MAHAJAN S, Barker CA, Singh B, Pandit-Taskar N, et al
    Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma.
    Nucl Med Commun. 2019 May 14. doi: 10.1097/MNM.0000000000001029.
    PubMed     Abstract available


  315. ZHOU J, Ju H, Zhu L, Pan Y, et al
    Value of fluorine-18-fluorodeoxyglucose PET/CT in localizing the primary lesion in adrenocorticotropic hormone-dependent Cushing syndrome.
    Nucl Med Commun. 2019;40:539-544.
    PubMed     Abstract available


  316. JIMENEZ-BONILLA JF, Quirce R, De Arcocha-Torres M, Martinez-Rodriguez I, et al
    A 5-year longitudinal evaluation in patients with mild cognitive impairment by 11C-PIB PET/CT: a visual analysis.
    Nucl Med Commun. 2019;40:525-531.
    PubMed     Abstract available


  317. KERAMIDA G, Peters AM
    Tissue standardized uptake value is a closer surrogate of blood fluorine-18 fluorodeoxyglucose clearance after division by blood standardized uptake value, illustrated in brain and liver.
    Nucl Med Commun. 2019;40:552-554.
    PubMed     Abstract available


  318. SAGER S, Akgun E, Uslu-Besli L, Asa S, et al
    Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma.
    Nucl Med Commun. 2019;40:461-468.
    PubMed     Abstract available


  319. XIN W, Yang X, Wang J, Shao X, et al
    Gated single-photon emission computed tomography myocardial perfusion imaging is superior to computed tomography attenuation correction in discriminating myocardial infarction from attenuation artifacts in men and right coronary artery disease.
    Nucl Med Commun. 2019;40:491-498.
    PubMed     Abstract available


  320. SERAJ SM, Al-Zaghal A, Zadeh MZ, Jahangiri P, et al
    Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMI.
    Nucl Med Commun. 2019;40:545-551.
    PubMed     Abstract available


    April 2019
  321. EVANGELISTA L, Cuppari L, Menis J, Bonanno L, et al
    18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy.
    Nucl Med Commun. 2019 Apr 30. doi: 10.1097/MNM.0000000000001025.
    PubMed     Abstract available


  322. DERAKHSHAN JJ, Farwell MD
    Prevalence and quantitative analysis of indium-111 pentetreotide (Octreoscan) uptake in the pancreatic head on SPECT/CT imaging: establishing a region of interest-based pathological uptake threshold.
    Nucl Med Commun. 2019 Apr 24. doi: 10.1097/MNM.0000000000001022.
    PubMed     Abstract available


  323. ZHANG H, Xiao J, Zhou J, Tan H, et al
    18F-PBR06 PET/CT imaging for evaluating atherosclerotic plaques linked to macrophage infiltration.
    Nucl Med Commun. 2019;40:370-376.
    PubMed     Abstract available


  324. SOMMERAUER M, Galldiks N, Barbe MT, Stoffels G, et al
    Cis-4-[18F]fluoro-D-proline detects neurodegeneration in patients with akinetic-rigid parkinsonism.
    Nucl Med Commun. 2019;40:383-387.
    PubMed     Abstract available


  325. KALDEWAY HP, Ter Borg EJ, van de Garde EMW, Habraken JBA, et al
    Validation of quantitative salivary gland scintigraphy in relation to the American-European concensus criteria for Sjogren's syndrome.
    Nucl Med Commun. 2019;40:343-348.
    PubMed     Abstract available


  326. ARORA Y, Singh RS, Sampath S, Sood A, et al
    Impact of hibernating and viable myocardium on improvement in perfusion and left ventricular ejection fraction after coronary artery bypass graft.
    Nucl Med Commun. 2019;40:325-332.
    PubMed     Abstract available


  327. HELLINGMAN D, Wan OY, de Wit-van der Veen BJ, van der Ploeg IM, et al
    Predictive risk factors for sentinel lymph node nonvisualization on planar lymphoscintigraphy using an intratumoral injection in patients with primary breast cancer.
    Nucl Med Commun. 2019;40:317-324.
    PubMed     Abstract available


    March 2019
  328. TSAO CH, Wu CY, Chang CW, Wang HE, et al
    Micro-PET imaging of [18F]fluoroacetate combined with [18F]FDG to differentiate chronic Mycobacterium tuberculosis infection from an acute bacterial infection in a mouse model: a preliminary study.
    Nucl Med Commun. 2019 Mar 29. doi: 10.1097/MNM.0000000000001017.
    PubMed     Abstract available


  329. CEGLA P, Joanna K, Sebastian G, Julian M, et al
    Correlation between tumour biology status measured in triple-tracer 18F-fluorodeoxyglucose-18F-fluorothymidine- 18F-fluoromisonidazole-PET/CT study and human papillomavirus status in patients with head and neck cancer.
    Nucl Med Commun. 2019 Mar 28. doi: 10.1097/MNM.0000000000001016.
    PubMed     Abstract available


  330. ACAR E, Turgut B, Yigit S, Kaya G, et al
    Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer.
    Nucl Med Commun. 2019 Mar 28. doi: 10.1097/MNM.0000000000001019.
    PubMed     Abstract available


  331. PURANDARE NC, Puranik A, Shah S, Agrawal A, et al
    Can 18F-FDG PET/CT diagnose malignant change in benign chondroid tumors?
    Nucl Med Commun. 2019 Mar 27. doi: 10.1097/MNM.0000000000001015.
    PubMed     Abstract available


  332. KHANDANI AH, Commander CW, Desai H, Oldan JD, et al
    Visual and semiquantitative analysis of 82Rb uptake in malignant tumors on PET/CT: first systematic analysis.
    Nucl Med Commun. 2019 Mar 26. doi: 10.1097/MNM.0000000000001011.
    PubMed     Abstract available


  333. SAMBRI A, Bianchi G, Longhi A, Righi A, et al
    The role of 18F-FDG PET/CT in soft tissue sarcoma.
    Nucl Med Commun. 2019 Mar 22. doi: 10.1097/MNM.0000000000001002.
    PubMed     Abstract available


  334. BASHIR U, Weeks A, Goda JS, Siddique M, et al
    Measurement of 18F-FDG PET tumor heterogeneity improves early assessment of response to bevacizumab compared with the standard size and uptake metrics in a colorectal cancer model.
    Nucl Med Commun. 2019 Mar 18. doi: 10.1097/MNM.0000000000000992.
    PubMed     Abstract available


  335. KITA A, Onoguchi M, Shibutani T, Horita H, et al
    Standardization of the specific binding ratio in [123I]FP-CIT SPECT: study by striatum phantom.
    Nucl Med Commun. 2019 Mar 18. doi: 10.1097/MNM.0000000000001010.
    PubMed     Abstract available


  336. DROUET C, Goehringer F, Tissot H, Manca C, et al
    An enlarged left adrenal gland is an indirect sign of infection on 18F-FDG PET/CT.
    Nucl Med Commun. 2019 Mar 14. doi: 10.1097/MNM.0000000000001013.
    PubMed     Abstract available


  337. WONDERGEM M, van der Zant FM, Rafimanesh-Sadr L, Knol RJJ, et al
    Effect of forced diuresis during 18F-DCFPyL PET/CT in patients with prostate cancer: activity in ureters, kidneys and bladder and occurrence of halo artefacts around kidneys and bladder.
    Nucl Med Commun. 2019 Mar 5. doi: 10.1097/MNM.0000000000001007.
    PubMed     Abstract available


  338. WATANABE S, Hanaoka K, Shibata Y, Kaida H, et al
    Usefulness of respiratory-gated 18F-FDG PET/CT scan protocol in patients having positive myocardial 18F-FDG uptake.
    Nucl Med Commun. 2019;40:235-241.
    PubMed     Abstract available


  339. ARMSTRONG IS
    Spatial dependence of activity concentration recovery for a conjugate gradient (Siemens xSPECT) algorithm using manufacturer-defined reconstruction presets.
    Nucl Med Commun. 2019;40:287-293.
    PubMed     Abstract available


  340. ESCUDERO-CASTELLANOS A, Ocampo-Garcia B, Ferro-Flores G, Santos-Cuevas C, et al
    Synthesis and preclinical evaluation of the 177Lu-DOTA-PSMA(inhibitor)-Lys3-bombesin heterodimer designed as a radiotheranostic probe for prostate cancer.
    Nucl Med Commun. 2019;40:278-286.
    PubMed     Abstract available


  341. ZHOU Y, Li D, Tang H, Xu Y, et al
    Development and validation of a new method to diagnose apical hypertrophic cardiomyopathy by gated single-photon emission computed tomography myocardial perfusion imaging.
    Nucl Med Commun. 2019;40:206-211.
    PubMed     Abstract available


  342. HAN YH, Jeong HJ, Sohn MH, Yoon SJ, et al
    Incidence and severity of femoral head avascularity after femoral neck or intertrochanteric fractures on preoperative bone single photon emission computed tomography/computed tomography: preliminary study.
    Nucl Med Commun. 2019;40:199-205.
    PubMed     Abstract available


  343. BHUSARI P, Bhatt J, Sood A, Kaur R, et al
    Evaluating the potential of kit-based 68Ga-ubiquicidin formulation in diagnosis of infection: a pilot study68Ga.
    Nucl Med Commun. 2019;40:228-234.
    PubMed     Abstract available


    February 2019
  344. BHOIL A, Vinjamuri S
    Role of 18F-FDG PET/CT in infection of cardiovascular implantable electronic devices: review of the literature and initial experience.
    Nucl Med Commun. 2019 Feb 21. doi: 10.1097/MNM.0000000000000995.
    PubMed     Abstract available


  345. DURMO R, Lechiara M, Benetti D, Rodella C, et al
    Radioguided lung lesion localization: introducing a fluoroscopy system in a SPECT/CT scan.
    Nucl Med Commun. 2019 Feb 15. doi: 10.1097/MNM.0000000000000999.
    PubMed     Abstract available


  346. ROBIN P, Klein R, Gardner J, Ziebarth B, et al
    Quantitative analysis of technetium-99m-sestamibi uptake and washout in parathyroid scintigraphy supports dual mechanisms of lesion conspicuity.
    Nucl Med Commun. 2019 Feb 12. doi: 10.1097/MNM.0000000000000996.
    PubMed     Abstract available


  347. TRUFFAULT B, Robin P, Tromeur C, Le Duc Pennec A, et al
    Time trend analysis of pulmonary embolism diagnosis with single-photon emission computed tomography ventilation/perfusion imaging.
    Nucl Med Commun. 2019 Feb 7. doi: 10.1097/MNM.0000000000000990.
    PubMed     Abstract available


  348. TANOUE Y, Nanashima A, Yano K, Fujii Y, et al
    Significance of the preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the future remnant liver: a sequential study of regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the wh
    Nucl Med Commun. 2019;40:145-152.
    PubMed     Abstract available


  349. BHOIL A, Ferdousi Begum SM, Vinjamuri S, Bomanji J, et al
    Challenges using PET-CT for international multicentre coordinated research projects in developing countries.
    Nucl Med Commun. 2019;40:93-95.
    PubMed    


  350. O'SHAUGHNESSY ER, Murray A, Taylor JC, Barnfield M, et al
    2015 UK software audit of hepatobiliary scintigraphy.
    Nucl Med Commun. 2019;40:136-144.
    PubMed     Abstract available


  351. BARNA S, Rozsa D, Varga J, Fodor A, et al
    First comparative results about the direct effect of traditional cigarette and e-cigarette smoking on lung alveolocapillary membrane using dynamic ventilation scintigraphy.
    Nucl Med Commun. 2019;40:153-158.
    PubMed     Abstract available


  352. KRZHIVITSKII PI, Novikov SN, Kanaev SV, Krivorotko PV, et al
    The use of single-photon emission computed tomography-computed tomography in detecting multiple metastatic lymph nodes in patients with breast cancer.
    Nucl Med Commun. 2019;40:169-174.
    PubMed     Abstract available


  353. KITA A, Onoguchi M, Shibutani T, Sugimoto K, et al
    Influence of myocardial count on phase dyssynchrony analysis of gated myocardial perfusion single-photon emission computed tomography.
    Nucl Med Commun. 2019;40:124-130.
    PubMed     Abstract available


  354. ZHANG F, Tian Y, Yang W, Shao X, et al
    Myocardial perfusion imaging detects mechanical dyssynchrony in left ventricular infarcted and noninfarcted areas early after acute myocardial infarction in a porcine model.
    Nucl Med Commun. 2019;40:115-123.
    PubMed     Abstract available


  355. MATSUTOMO N, Fukaya K, Hashimoto T, Yamamoto T, et al
    Performance of compressed sensing-based iterative reconstruction for single-photon emission computed tomography from undersampled projection data: a simulation study in 123I-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iodophenyl)nortropane imagi
    Nucl Med Commun. 2019;40:106-114.
    PubMed     Abstract available


    January 2019
  356. GALLAND L, Bolot C, Rosinski S, Bruno A, et al
    Radiochemical purity of technetium-99m-nanocolloid rhenium sulphide is not influenced by heating.
    Nucl Med Commun. 2019 Jan 31. doi: 10.1097/MNM.0000000000000988.
    PubMed     Abstract available


  357. KOMEK H, Can C, Urakci Z, Kepenek F, et al
    Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Nucl Med Commun. 2019 Jan 28. doi: 10.1097/MNM.0000000000000985.
    PubMed     Abstract available


  358. DAI D, Chuang HH, Macapinlac HA, Li T, et al
    Correlation of fluorine 18-labeled sodium fluoride uptake and arterial calcification on whole-body PET/CT in cancer patients.
    Nucl Med Commun. 2019 Jan 25. doi: 10.1097/MNM.0000000000000986.
    PubMed     Abstract available


  359. RASSAM F, Cieslak KP, Beuers UHW, van Gulik TM, et al
    Stress test of liver function using technetium-99m-mebrofenin hepatobiliary scintigraphy.
    Nucl Med Commun. 2019 Jan 22. doi: 10.1097/MNM.0000000000000979.
    PubMed     Abstract available


  360. MALIHA PG, Hudson M, Abikhzer G, Singerman J, et al
    18F-FDG PET/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications.
    Nucl Med Commun. 2019 Jan 18. doi: 10.1097/MNM.0000000000000981.
    PubMed     Abstract available


  361. PERKINS AC
    Amersham radiopharmaceuticals: a global scientific and industrial legacy for nuclear medicine.
    Nucl Med Commun. 2019 Jan 18. doi: 10.1097/MNM.0000000000000984.
    PubMed    


  362. WANG L, Bai J, Duan P
    Prognostic value of 18F-FDG PET/CT functional parameters in patients with head and neck cancer: a meta-analysis.
    Nucl Med Commun. 2019 Jan 18. doi: 10.1097/MNM.0000000000000974.
    PubMed     Abstract available


  363. BROMINSKA B, Czepczynski R, Gabryel P, Jarmolowska-Jurczyszyn D, et al
    18F-FDG PET/CT and nestin expression as prognostic tools in pulmonary neuroendocrine tumours.
    Nucl Med Commun. 2019 Jan 10. doi: 10.1097/MNM.0000000000000972.
    PubMed     Abstract available


  364. BARBARA RR, Pawaroo D, Beadsmoore C, Hujairi N, et al
    Parotid incidentalomas on positron emission tomography: what is their clinical significance?
    Nucl Med Commun. 2019 Jan 5. doi: 10.1097/MNM.0000000000000961.
    PubMed     Abstract available


  365. LOUTFI I
    Medical nuclomics: a new order in nuclear medicine practice.
    Nucl Med Commun. 2019 Jan 5. doi: 10.1097/MNM.0000000000000975.
    PubMed    


  366. GOMEZ-DE LA FUENTE FJ, Martinez-Rodriguez I, De Arcocha-Torres M, Quirce R, et al
    Effect of positive carbon-11-choline PET/CT results in the therapeutic management of prostate cancer biochemical relapse.
    Nucl Med Commun. 2019;40:79-85.
    PubMed     Abstract available


  367. KERAMIDA G, Peters AM
    The appropriate whole body metric for calculating standardised uptake value and the influence of sex.
    Nucl Med Commun. 2019;40:3-7.
    PubMed     Abstract available


  368. JOHNSTON BA, Nicol A, Bolster A, Wright J, et al
    Development and validation of a full model of a four-headed neuroimaging single-photon emission computed tomography scanner.
    Nucl Med Commun. 2019;40:14-21.
    PubMed     Abstract available


    December 2018
  369. RASSAM F, Olthof PB, Richardson H, van Gulik TM, et al
    Practical guidelines for the use of technetium-99m mebrofenin hepatobiliary scintigraphy in the quantitative assessment of liver function.
    Nucl Med Commun. 2018 Dec 28. doi: 10.1097/MNM.0000000000000973.
    PubMed     Abstract available


  370. YILMAZ B, Dag S, Ergul N, Cermik TF, et al
    The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
    Nucl Med Commun. 2018 Dec 24. doi: 10.1097/MNM.0000000000000969.
    PubMed     Abstract available


  371. DERCLE L, Billey C, Cognet T, Cassol E, et al
    Spleno-hepatic index to predict portal hypertension by equilibrium radionuclide ventriculography.
    Nucl Med Commun. 2018;39:1138-1142.
    PubMed     Abstract available


    November 2018
  372. GIOVACCHINI G, Giovannini E, Borso E, Lazzeri P, et al
    Sensitivity of fluorine-18-fluoromethylcholine PET/CT to prostate-specific antigen over different plasma levels: a retrospective study in a cohort of 192 patients with prostate cancer.
    Nucl Med Commun. 2018 Nov 29. doi: 10.1097/MNM.0000000000000959.
    PubMed     Abstract available


  373. YAN Y, Somer E, Grau V
    Classification of amyloid PET images using novel features for early diagnosis of Alzheimer's disease and mild cognitive impairment conversion.
    Nucl Med Commun. 2018 Nov 29. doi: 10.1097/MNM.0000000000000953.
    PubMed     Abstract available


  374. MICHOPOULOU S, O'Shaughnessy E, Thomson K, Guy MJ, et al
    Discovery Molecular Imaging Digital Ready PET/CT performance evaluation according to the NEMA NU2-2012 standard.
    Nucl Med Commun. 2018 Nov 27. doi: 10.1097/MNM.0000000000000962.
    PubMed     Abstract available


  375. VOLTIN CA, Mettler J, Boellaard R, Kuhnert G, et al
    Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction?
    Nucl Med Commun. 2018 Nov 19. doi: 10.1097/MNM.0000000000000956.
    PubMed     Abstract available


  376. BROOS WAM, van der Zant FM, Knol RJJ, Wondergem M, et al
    Choline PET/CT in parathyroid imaging: a systematic review.
    Nucl Med Commun. 2018 Nov 15. doi: 10.1097/MNM.0000000000000952.
    PubMed     Abstract available


  377. ROSARIO PW, Rocha TG, Calsolari MR
    Fluorine-18-fluorodeoxyglucose positron emission tomography in thyroid nodules with indeterminate cytology: a prospective study.
    Nucl Med Commun. 2018 Nov 15. doi: 10.1097/MNM.0000000000000946.
    PubMed     Abstract available


  378. BIALEK EJ, Malkowski B
    Celiac ganglia: can they be misinterpreted on multimodal 68Ga-PSMA-11 PET/MR?
    Nucl Med Commun. 2018 Nov 14. doi: 10.1097/MNM.0000000000000944.
    PubMed     Abstract available


  379. DING Y, Wu S, Xu J, Wang H, et al
    Pituitary 18F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on 18F-FDG PET/CT.
    Nucl Med Commun. 2018 Nov 12. doi: 10.1097/MNM.0000000000000940.
    PubMed     Abstract available


  380. DEMIRCI E, Kabasakal L, Sahin OE, Akgun E, et al
    Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
    Nucl Med Commun. 2018 Nov 2. doi: 10.1097/MNM.0000000000000942.
    PubMed     Abstract available


  381. ABUQBEITAH M, Demir M, Kabasakal L, Cavdar I, et al
    Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer.
    Nucl Med Commun. 2018;39:969-975.
    PubMed     Abstract available


  382. OKADA Y, Shiraishi M, Nakamura H, Maki F, et al
    Usefulness of the combination of iodine-123-metaiodobenzylguanidine scintigraphy and iodine-123-ioflupane scintigraphy in new-onset Parkinson's disease.
    Nucl Med Commun. 2018;39:983-988.
    PubMed     Abstract available


    October 2018
  383. PRABHU M, Kumari G, Damle NA, Arora G, et al
    Assessment of the role of early dynamic PET/CT with 18F-fluorocholine in detection of parathyroid lesions in patients with primary hyperparathyroidism.
    Nucl Med Commun. 2018 Oct 30. doi: 10.1097/MNM.0000000000000924.
    PubMed     Abstract available


  384. BASHIR U, Foot O, Wise O, Siddique MM, et al
    Investigating the histopathologic correlates of 18F-FDG PET heterogeneity in non-small-cell lung cancer.
    Nucl Med Commun. 2018 Oct 30. doi: 10.1097/MNM.0000000000000925.
    PubMed     Abstract available


  385. BETTS HM, O'Connor RA, Christian JA, Vinayakamoorthy V, et al
    Hypoxia imaging with [18F]HX4 PET in squamous cell head and neck cancers: a pilot study for integration into treatment planning.
    Nucl Med Commun. 2018 Oct 26. doi: 10.1097/MNM.0000000000000933.
    PubMed     Abstract available


  386. SHARMA A, Pandey AK, Mohan A, Bhalla AS, et al
    Standardization of image reconstruction parameters for dynamic fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
    Nucl Med Commun. 2018 Oct 26. doi: 10.1097/MNM.0000000000000923.
    PubMed     Abstract available


  387. HALL M
    Artificial intelligence and nuclear medicine.
    Nucl Med Commun. 2018 Oct 22. doi: 10.1097/MNM.0000000000000937.
    PubMed    


  388. KLEIN R, Razavi S, Memon R, Zuckier LS, et al
    An electronic technetium-99m-diethylenetriaminepentaacetic acid glomerular filtration rate spreadsheet with novel embedded quality assurance features.
    Nucl Med Commun. 2018 Oct 22. doi: 10.1097/MNM.0000000000000929.
    PubMed     Abstract available


  389. EVBUOMWAN O, Momodu J, Purbhoo K, Vangu MDT, et al
    Evaluation of technetium-99m metastable nanocolloid as an imaging agent for performing milk scans.
    Nucl Med Commun. 2018 Oct 17. doi: 10.1097/MNM.0000000000000934.
    PubMed     Abstract available


  390. VUKOMANOVIC VR, Matovic M, Doknic M, Ignjatovic V, et al
    Clinical usefulness of 99mTc-HYNIC-TOC, 99mTc(V)-DMSA, and 99mTc-MIBI SPECT in the evaluation of pituitary adenomas.
    Nucl Med Commun. 2018 Oct 16. doi: 10.1097/MNM.0000000000000931.
    PubMed     Abstract available


  391. VADI SK, Mittal BR, Sood A, Singh G, et al
    Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer.
    Nucl Med Commun. 2018 Oct 11. doi: 10.1097/MNM.0000000000000928.
    PubMed     Abstract available


  392. MANSOOR NM, Thust S, Militano V, Fraioli F, et al
    PET imaging in glioma: techniques and current evidence.
    Nucl Med Commun. 2018 Oct 9. doi: 10.1097/MNM.0000000000000914.
    PubMed     Abstract available



  393. The prognostic and diagnostic value of 18F-FDG PET/CT for assessment of symptomatic osteoarthritis: Erratum.
    Nucl Med Commun. 2018;39:960.
    PubMed    


  394. SERRELI G, Ruffini L, Ortenzia O, Cidda C, et al
    Radiation dose reduction in myocardial perfusion imaging single-photon emission computed tomography/computed tomography using a dose-tracking software.
    Nucl Med Commun. 2018;39:894-900.
    PubMed     Abstract available


  395. YAZICI B, Bulut IK, Oral A, Sezer TO, et al
    Early predictive value of baseline renal transplant scintigraphy in pediatric patients.
    Nucl Med Commun. 2018;39:901-907.
    PubMed     Abstract available


  396. KIM DH, Wit H, Thurston M
    Artificial intelligence in the diagnosis of Parkinson's disease from ioflupane-123 single-photon emission computed tomography dopamine transporter scans using transfer learning.
    Nucl Med Commun. 2018;39:887-893.
    PubMed     Abstract available


  397. LEE SF, Lichtenstein M, Hughes P, Sivaratnam D, et al
    Utility of MAG3 scintigraphy with the use of a 2 min uptake parameter in the assessment of postsurgical renal transplant complications.
    Nucl Med Commun. 2018;39:921-927.
    PubMed     Abstract available


  398. NOTGHI A, Hansrod S
    National survey of gastric emptying studies in the UK.
    Nucl Med Commun. 2018;39:881-886.
    PubMed     Abstract available


  399. LIU S, Feng Z, Jiang Z, Wen H, et al
    Prognostic predictive value of preoperative intratumoral 2-deoxy-2-(18F)fluoro-D-glucose uptake heterogeneity in patients with high-grade serous ovarian cancer.
    Nucl Med Commun. 2018;39:928-935.
    PubMed     Abstract available


    September 2018
  400. NAKAJIMA R, Nagao M, Ohashi R, Muragaki Y, et al
    Modified fractal analysis of methionine positron emission tomography images for predicting prognosis in newly diagnosed patients with glioma.
    Nucl Med Commun. 2018 Sep 21. doi: 10.1097/MNM.0000000000000917.
    PubMed     Abstract available


  401. XUE J, Liu Y, Ji T, Zhao A, et al
    Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia.
    Nucl Med Commun. 2018 Sep 19. doi: 10.1097/MNM.0000000000000921.
    PubMed     Abstract available


  402. FUJIOKA T, Kubota K, Kikuchi Y, Tsuchiya J, et al
    The feasibility of using 18F-FDG-PET/CT in patients with mucinous breast carcinoma.
    Nucl Med Commun. 2018 Sep 18. doi: 10.1097/MNM.0000000000000910.
    PubMed     Abstract available


  403. GUNDOGAN C, Cermik TF, Erkan E, Yardimci AH, et al
    Role of contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of renal tumors.
    Nucl Med Commun. 2018 Sep 18. doi: 10.1097/MNM.0000000000000915.
    PubMed     Abstract available


  404. KANGASMAA TS, Constable C, Sohlberg AO
    Evaluation of quantitative 123I and 131I SPECT with Monte Carlo-based down-scatter compensation.
    Nucl Med Commun. 2018 Sep 14. doi: 10.1097/MNM.0000000000000920.
    PubMed     Abstract available


  405. ANNOVAZZI A, Rea S, Vici P, Fabi A, et al
    Dual-time 18F-FDG PET/CT for the detection of liver metastases in breast cancer.
    Nucl Med Commun. 2018 Sep 13. doi: 10.1097/MNM.0000000000000918.
    PubMed     Abstract available


  406. SASIKUMAR A, Joy A, Pillai AMR, Oommen KE, et al
    Gallium 68-PSMA PET/CT for lesion characterization in suspected cases of prostate carcinoma.
    Nucl Med Commun. 2018 Sep 13. doi: 10.1097/MNM.0000000000000906.
    PubMed     Abstract available


  407. EVBUOMWAN O, Purbhoo K, Vangu MDT
    A prospective study comparing 99mTc-MIBI and 99mTc-MDP with 99mTc-DTPA for lung ventilation scintigraphy in pulmonary thromboembolism.
    Nucl Med Commun. 2018 Sep 13. doi: 10.1097/MNM.0000000000000913.
    PubMed     Abstract available


  408. MOSAYEBNIA M, Hajiramezanali M, Shahhosseini S, Hajiagha Bozorgi A, et al
    Docking, synthesis, in-vitro evaluation, and optimization of reaction conditions for direct radiolabeling of CGPRPPC with technetium-99m through the GAGG sequence.
    Nucl Med Commun. 2018 Sep 12. doi: 10.1097/MNM.0000000000000901.
    PubMed     Abstract available


  409. PAK K, Shin S, Kim SJ, Kim K, et al
    Meta-analysis of meta-analyses in oncologic positron emission tomography.
    Nucl Med Commun. 2018 Sep 12. doi: 10.1097/MNM.0000000000000908.
    PubMed     Abstract available


  410. ZHANG L, Sun H, Du S, Xu W, et al
    Evaluation of 18F-FDG PET/CT parameters for reflection of aggressiveness and prediction of prognosis in early-stage cervical cancer.
    Nucl Med Commun. 2018 Sep 10. doi: 10.1097/MNM.0000000000000909.
    PubMed     Abstract available


  411. WIERTS R, Conti M, Claessen AGG, Herrmann K, et al
    Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124I PET/CT imaging.
    Nucl Med Commun. 2018 Sep 7. doi: 10.1097/MNM.0000000000000911.
    PubMed     Abstract available


  412. HAIDAR M, Baassiri A, Maroun G, Barakat A, et al
    New era of PET/CT in breast cancer: high-resolution PET/dfCT.
    Nucl Med Commun. 2018 Sep 6. doi: 10.1097/MNM.0000000000000907.
    PubMed     Abstract available


  413. BARBER TW, Veysey D, Billah B, Francis P, et al
    Normal brain metabolism on FDG PET/MRI during childhood and adolescence.
    Nucl Med Commun. 2018 Sep 6. doi: 10.1097/MNM.0000000000000912.
    PubMed     Abstract available


  414. LAWAL IO, Ankrah AO, Popoola GO, Nyakale NE, et al
    18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma.
    Nucl Med Commun. 2018 Sep 5. doi: 10.1097/MNM.0000000000000905.
    PubMed     Abstract available


  415. AKTAS GE, Karamustafaoglu YA, Balta C, Sut N, et al
    Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
    Nucl Med Commun. 2018 Sep 4. doi: 10.1097/MNM.0000000000000903.
    PubMed     Abstract available


  416. FILIPPI L, Di Costanzo GG, D'Agostini A, Tortora R, et al
    Decrease in total lesion glycolysis and survival after yttrium-90-radioembolization in poorly differentiated hepatocellular carcinoma with portal vein tumour thrombosis.
    Nucl Med Commun. 2018;39:845-852.
    PubMed     Abstract available


  417. DICKINSON NJ, Kalirai C, O'Connor RA, Mullin K, et al
    Hepatic selective internal radiation therapy: how well does pretreatment 99mTc-macroaggregated albumin activity distribution and quantification agree with post-therapy bremsstrahlung imaging?
    Nucl Med Commun. 2018;39:809-817.
    PubMed     Abstract available


  418. LIU NH, Dong MJ, Liu H, Lu XL, et al
    99mTc-Phy portal perfusion index imaging helps predict the severity of hepatitis B virus cirrhosis: a preliminary study.
    Nucl Med Commun. 2018;39:818-824.
    PubMed     Abstract available


    August 2018
  419. ARAZ M, Soydal C, Ozkan E, Kir MK, et al
    The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism.
    Nucl Med Commun. 2018 Aug 22. doi: 10.1097/MNM.0000000000000899.
    PubMed     Abstract available


  420. SANLI Y, Sanli O, Has Simsek D, Subramaniam RM, et al
    68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patients.
    Nucl Med Commun. 2018 Aug 17. doi: 10.1097/MNM.0000000000000888.
    PubMed     Abstract available


  421. D'AGOSTINO GR, Lopci E, Di Brina L, Franzese C, et al
    Role of 11C-choline PET/CT in radiation therapy planning of patients with prostate cancer.
    Nucl Med Commun. 2018 Aug 17. doi: 10.1097/MNM.0000000000000894.
    PubMed     Abstract available


  422. BRINKMAN M, Jentjens S, Boone K, Anten M, et al
    Evaluation of the most commonly used (semi-)quantitative parameters of 18F-FDG PET/CT to detect malignant transformation of neurofibromas in neurofibromatosis type 1.
    Nucl Med Commun. 2018 Aug 13. doi: 10.1097/MNM.0000000000000889.
    PubMed     Abstract available


  423. AYUBCHA C, Zirakchian Zadeh M, Stochkendahl MJ, Al-Zaghal A, et al
    Quantitative evaluation of normal spinal osseous metabolism with 18F-NaF PET/CT.
    Nucl Med Commun. 2018 Aug 9. doi: 10.1097/MNM.0000000000000891.
    PubMed     Abstract available


  424. CHHABRA A, Rathore Y, Bhusari P, Vatsa R, et al
    Concentration protocol of rhenium-188 perrhenate eluted from tungsten-188/rhenium-188 generator for the preparation of high-yield rhenium-188-labelled radiopharmaceuticals.
    Nucl Med Commun. 2018 Aug 6. doi: 10.1097/MNM.0000000000000893.
    PubMed     Abstract available


  425. LIU W, Sun X, Qi Y, Jia X, et al
    Integrated texture parameter of 18F-FDG PET may be a stratification factor for the survival of nonoperative patients with locally advanced non-small-cell lung cancer.
    Nucl Med Commun. 2018;39:732-740.
    PubMed     Abstract available


  426. SUN Y, Liu S, Feng Z, Cheng J, et al
    Preoperative omental metastasis-related maximum standardized fluorine-18-fluorodeoxyglucose uptake value can predict chemosensitivity and recurrence in advanced high-grade serous ovarian cancer patients.
    Nucl Med Commun. 2018;39:761-767.
    PubMed     Abstract available


  427. DEMIRCI E, Kabasakal L, Toklu T, Ocak M, et al
    177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update.
    Nucl Med Commun. 2018;39:789-796.
    PubMed     Abstract available


  428. JIANG Z, Tang H, Shi J, Zhou Y, et al
    Myocardial stunning-induced left ventricular dyssynchrony on gated single-photon emission computed tomography myocardial perfusion imaging.
    Nucl Med Commun. 2018;39:725-731.
    PubMed     Abstract available


  429. TORIIHARA A, Daisaki H, Yamaguchi A, Yoshida K, et al
    Applying standardized uptake values in gallium-67-citrate single-photon emission computed tomography/computed tomography studies and their correlation with blood test results in representative organs.
    Nucl Med Commun. 2018;39:720-724.
    PubMed     Abstract available


    July 2018
  430. ABUBAKAR S, Jacobs D, Kotze T
    The conclusions drawn from ventilation/perfusion single-photon emission computed tomography compared with lung perfusion single-photon emission computed tomography and chest radiography in patients with suspected pulmonary thromboembolism.
    Nucl Med Commun. 2018 Jul 25. doi: 10.1097/MNM.0000000000000886.
    PubMed     Abstract available


  431. CORNELI M, Masoli O, Perea G, Meretta A, et al
    Actual impact of screening for myocardial ischemia with single-photon emission tomography among patients undergoing peripheral vascular interventions.
    Nucl Med Commun. 2018 Jul 23. doi: 10.1097/MNM.0000000000000883.
    PubMed     Abstract available


  432. WAGATSUMA K, Oda K, Sakata M, Inaji M, et al
    Validation of scatter limitation correction to eliminate scatter correction error in oxygen-15 gas-inhalation positron emission tomography images.
    Nucl Med Commun. 2018 Jul 6. doi: 10.1097/MNM.0000000000000882.
    PubMed     Abstract available


  433. NGUYEN BJ, Burt A, Baldassare RL, Smitaman E, et al
    The prognostic and diagnostic value of 18F-FDG PET/CT for assessment of symptomatic osteoarthritis.
    Nucl Med Commun. 2018;39:699-706.
    PubMed     Abstract available


  434. KIM HR, Seo M, Nah YW, Park HW, et al
    Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival.
    Nucl Med Commun. 2018;39:691-698.
    PubMed     Abstract available


  435. ARSLAN E, Cermik TF, Trabulus FDC, Talu ECK, et al
    Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer.
    Nucl Med Commun. 2018;39:680-690.
    PubMed     Abstract available


  436. LI YB, Zheng X, Wang R, Wu H, et al
    SPECT-CT versus MRI in localizing active lesions in patients with osteoporotic vertebral compression fractures.
    Nucl Med Commun. 2018;39:610-617.
    PubMed     Abstract available


  437. TSUJIMOTO M, Shirakawa S, Teramoto A, Ishiguro M, et al
    Fluctuation of quantitative values on acquisition time and the reconstruction conditions in 99mTc-SPECT.
    Nucl Med Commun. 2018;39:601-609.
    PubMed     Abstract available


  438. KURISU S, Nitta K, Sumimoto Y, Ikenaga H, et al
    Effects of atrial fibrillation on myocardial washout rate of thallium-201 on myocardial perfusion single-photon emission computed tomography.
    Nucl Med Commun. 2018;39:597-600.
    PubMed     Abstract available


    June 2018
  439. MOHAMMADINIA S, Abedi SM, Noaparast Z
    St. John's Wort accelerates the liver clearance of technetium-99-sestamibi in rats.
    Nucl Med Commun. 2018 Jun 26. doi: 10.1097/MNM.0000000000000880.
    PubMed     Abstract available


  440. CHATTERJEE A, Gupta T, Rangarajan V, Purandare N, et al
    Optimal timing of fluorine-18-fluoromisonidazole positron emission tomography/computed tomography for assessment of tumor hypoxia in patients with head and neck squamous cell carcinoma.
    Nucl Med Commun. 2018 Jun 22. doi: 10.1097/MNM.0000000000000878.
    PubMed     Abstract available


  441. EMSEN B, Benali K, Mahida B, Lariviere D, et al
    Comparison between visual and numerical metrics for the evaluation of patients with Takayasu arteritis with 18F-FDG-PET.
    Nucl Med Commun. 2018 Jun 8. doi: 10.1097/MNM.0000000000000867.
    PubMed     Abstract available


  442. MACAULEY M, Shawgi M, Ali T, Curry A, et al
    Assessment of normal reference values for thyroid uptake of technetium-99m pertechnetate in a single centre UK population.
    Nucl Med Commun. 2018 Jun 6. doi: 10.1097/MNM.0000000000000876.
    PubMed     Abstract available


  443. DEVRIESE J, Beels L, Maes A, van de Wiele C, et al
    Patient-specific lean body mass can be estimated from limited-coverage computed tomography images.
    Nucl Med Commun. 2018;39:521-526.
    PubMed     Abstract available


  444. YILDIRIM BA, Torun N, Guler OC, Onal C, et al
    Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy.
    Nucl Med Commun. 2018;39:553-563.
    PubMed     Abstract available


  445. YILMAZ R, Yumusak N, Sadic M, Atilgan HI, et al
    The scintigraphic, biodistribution and histopathological evaluation of the effect of experimental 131I administration on the gastrointestinal system and the demonstration of the Na+/I- symporter by immunohistochemistry in rats.
    Nucl Med Commun. 2018;39:511-520.
    PubMed     Abstract available


  446. CHIARAVALLOTI A, Barbagallo G, Ricci M, Sannino P, et al
    Ageing effect on 18F-DOPA and 123I-MIBG uptake: a cross-sectional study.
    Nucl Med Commun. 2018;39:539-544.
    PubMed     Abstract available


    May 2018
  447. SHARMA S, Singh AD, Sharma SK, Tripathi M, et al
    Gallium-68 DOTA-NOC PET/CT as an alternate predictor of disease activity in sarcoidosis.
    Nucl Med Commun. 2018 May 30. doi: 10.1097/MNM.0000000000000869.
    PubMed     Abstract available


  448. MALLORIE A, Chan K, Ioannidis S, Stubbs M, et al
    A case series of outcomes in isolated subsegmental pulmonary embolism on ventilation-perfusion imaging.
    Nucl Med Commun. 2018 May 25. doi: 10.1097/MNM.0000000000000866.
    PubMed     Abstract available


  449. VIJA RACARU L, Sinigaglia M, Kanoun S, Ben Bouallegue F, et al
    Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.
    Nucl Med Commun. 2018 May 21. doi: 10.1097/MNM.0000000000000850.
    PubMed     Abstract available


  450. ALBANO D, Familiari D, Gentile R, Scalisi S, et al
    Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer.
    Nucl Med Commun. 2018 May 18. doi: 10.1097/MNM.0000000000000862.
    PubMed     Abstract available


  451. SUGITA T, Kondo Y, Ishino S, Mori I, et al
    Evaluation of drug effects on cerebral blood flow and glucose uptake in un-anesthetized and un-stimulated rats: application of free-moving apparatus enabling to keep rats free during PET/SPECT tracer injection and uptake.
    Nucl Med Commun. 2018 May 15. doi: 10.1097/MNM.0000000000000863.
    PubMed     Abstract available


  452. KOUIJZER IJE, Berrevoets MAH, Aarntzen EHJG, de Vries J, et al
    18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis.
    Nucl Med Commun. 2018 May 14. doi: 10.1097/MNM.0000000000000864.
    PubMed     Abstract available


  453. LU Z, Xie J, Yan R, Yu Z, et al
    A pilot study of pancreatic islet amyloid PET imaging with [18F]FDDNP.
    Nucl Med Commun. 2018 May 5. doi: 10.1097/MNM.0000000000000849.
    PubMed     Abstract available


  454. CAOBELLI F, Popescu CE, Laudicella R, Comis A, et al
    Predictive and prognostic value of left ventricular mechanical dyssynchrony assessed by myocardial perfusion single photon emission computed tomography in asymptomatic patients under hemodialysis.
    Nucl Med Commun. 2018;39:423-429.
    PubMed     Abstract available


  455. ROSICA D, Cheng SC, Hudson M, Sakellis C, et al
    Effects of hyperglycemia on fluorine-18-fluorodeoxyglucose biodistribution in a large oncology clinical practice.
    Nucl Med Commun. 2018;39:417-422.
    PubMed     Abstract available


    April 2018
  456. BELISSANT O, Champion L, Thevenet H, Weinmann P, et al
    Value of 18F-FDG PET/CT imaging in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas.
    Nucl Med Commun. 2018 Apr 20. doi: 10.1097/MNM.0000000000000848.
    PubMed     Abstract available


  457. GRUT H, Revheim ME, Line PD, Dueland S, et al
    Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation.
    Nucl Med Commun. 2018 Apr 20. doi: 10.1097/MNM.0000000000000843.
    PubMed     Abstract available


  458. PALANISWAMY SS, Borde CR, Subramanyam P
    18F-FDG PET/CT in the evaluation of cancer cervix: Where do we stand today?
    Nucl Med Commun. 2018 Apr 20. doi: 10.1097/MNM.0000000000000851.
    PubMed     Abstract available


  459. BORAKATI A, Razack A, Cawthorne C, Roy R, et al
    A comparative study of quantitative assessment with fluorine-18-fluorodeoxyglucose positron-emission tomography and endoscopic ultrasound in oesophageal cancer.
    Nucl Med Commun. 2018 Apr 18. doi: 10.1097/MNM.0000000000000844.
    PubMed     Abstract available


  460. ALKHAWTANI RHM, Noordzij W, Glaudemans AWJM, van Rijn RS, et al
    Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma.
    Nucl Med Commun. 2018 Apr 18. doi: 10.1097/MNM.0000000000000840.
    PubMed     Abstract available


  461. OWAKI Y, Nakahara T, Shimizu T, Smith AM, et al
    Effects of breathing motion on PET acquisitions: step and shoot versus continuous bed motion.
    Nucl Med Commun. 2018 Apr 18. doi: 10.1097/MNM.0000000000000852.
    PubMed     Abstract available


  462. GOENSE L, Meziani J, van Rossum PSN, Wessels FJ, et al
    Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis.
    Nucl Med Commun. 2018 Apr 18. doi: 10.1097/MNM.0000000000000847.
    PubMed     Abstract available


  463. QIU L, Tan H, Cheng D, Shi H, et al
    The incremental clinical value of cardiac hybrid SPECT/CTA imaging in coronary artery disease.
    Nucl Med Commun. 2018 Apr 12. doi: 10.1097/MNM.0000000000000838.
    PubMed     Abstract available


  464. SCHIRMER MR, Carneiro MP, Machado LS, Chaves ALDS, et al
    Fluorine-18-fluorodeoxyglucose PET/CT in hematopoietic stem cell transplant patients with fusariosis: initial findings of a case series review.
    Nucl Med Commun. 2018 Apr 12. doi: 10.1097/MNM.0000000000000834.
    PubMed     Abstract available


  465. ZHENG M, Xie D, Pan C, Xu Y, et al
    Diagnostic value of 18F-FDG PET/MRI in recurrent pelvis malignancies of female patients: a systematic review and meta-analysis.
    Nucl Med Commun. 2018 Apr 9. doi: 10.1097/MNM.0000000000000839.
    PubMed     Abstract available


  466. SUN M, Zhang G, Guo J, Hao S, et al
    Prognostic value of pretreatment PET/CT lean body mass-corrected parameters in patients with hepatocellular carcinoma.
    Nucl Med Commun. 2018 Apr 9. doi: 10.1097/MNM.0000000000000842.
    PubMed     Abstract available


  467. LAPA P, Pedroso de Lima J
    Superiority of 18F-NaF PET/CT for the detection of bone metastases.
    Nucl Med Commun. 2018;39:344-345.
    PubMed    


  468. TATAR G, Cermik TF, Karagoz Y, Gundogan C, et al
    The value of whole-body contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of patients with laryngeal carcinoma.
    Nucl Med Commun. 2018;39:334-342.
    PubMed     Abstract available


  469. LIU S, Ju X, Feng Z, Wen H, et al
    Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patients.
    Nucl Med Commun. 2018;39:319-324.
    PubMed     Abstract available


  470. MORELAND J, Urhemaa T, van Gils M, Lotjonen J, et al
    Validation of prognostic biomarker scores for predicting progression of dementia in patients with amnestic mild cognitive impairment.
    Nucl Med Commun. 2018;39:297-303.
    PubMed     Abstract available


  471. PELI A, Camoni L, Zilioli V, Durmo R, et al
    Attenuation correction in myocardial perfusion imaging affects the assessment of infarct size in women with previous inferior infarct.
    Nucl Med Commun. 2018;39:290-296.
    PubMed     Abstract available


    March 2018
  472. DENNIS JL, Gemmell AJ, Nicol AJ
    Optimization of the CT component of SPECT-CT and establishment of local CT diagnostic reference levels for clinical practice.
    Nucl Med Commun. 2018 Mar 31. doi: 10.1097/MNM.0000000000000831.
    PubMed     Abstract available


  473. BERGERON DE, Cessna JT
    An update on 'dose calibrator' settings for nuclides used in nuclear medicine.
    Nucl Med Commun. 2018 Mar 28. doi: 10.1097/MNM.0000000000000833.
    PubMed     Abstract available


  474. VAN DIJK JD, Huizing ED, van Dalen JA, Timmer JR, et al
    Minimal starting time of data reconstruction for qualitative myocardial perfusion rubidium-82 positron emission tomography imaging.
    Nucl Med Commun. 2018 Mar 23. doi: 10.1097/MNM.0000000000000830.
    PubMed     Abstract available


  475. MANDEGARAN R, Agrawal K, Vijayanathan S, Gnanasegaran G, et al
    The value of 99mTc-MDP bone SPECT/CT in evaluation of patients with painful knee prosthesis.
    Nucl Med Commun. 2018 Mar 16. doi: 10.1097/MNM.0000000000000825.
    PubMed     Abstract available


  476. ALMEIDA LS, Araujo MC, Zantut-Wittmann DE, Assumpcao LV, et al
    Effect of thyroid-stimulating hormone in 68Ga-DOTATATE PET/CT of radioiodine-refractory thyroid carcinoma: a pilot study.
    Nucl Med Commun. 2018 Mar 14. doi: 10.1097/MNM.0000000000000823.
    PubMed     Abstract available


  477. LEE JW, Lee SW, Chang SH, Lee SM, et al
    Clinical role of bone scintigraphy in low-to-intermediate Framingham risk patients with atypical chest pain.
    Nucl Med Commun. 2018 Mar 13. doi: 10.1097/MNM.0000000000000822.
    PubMed     Abstract available


  478. ANDERSEN TB, Aleksyniene R, Boldsen SK, Gade M, et al
    Contrast-enhanced computed tomography does not improve the diagnostic value of parathyroid dual-phase MIBI SPECT/CT.
    Nucl Med Commun. 2018 Mar 6. doi: 10.1097/MNM.0000000000000818.
    PubMed     Abstract available


  479. JONNAKUTI VS, Raynor WY, Taratuta E, Werner TJ, et al
    A novel method to assess subchondral bone formation using [18F]NaF-PET in the evaluation of knee degeneration.
    Nucl Med Commun. 2018 Mar 2. doi: 10.1097/MNM.0000000000000819.
    PubMed     Abstract available


  480. CALLAN PD, Bhandari S, Clark AL, Eadington D, et al
    The utility of myocardial perfusion imaging before renal transplantation: a retrospective analysis.
    Nucl Med Commun. 2018;39:228-235.
    PubMed     Abstract available


    February 2018
  481. THIENTUNYAKIT T, Sethanandha C, Muangpaisan W, Chawalparit O, et al
    Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer's disease: first-hand experience in Thailand.
    Nucl Med Commun. 2018;39:186-192.
    PubMed    


  482. DING X, Man X, Sun M, Xing J, et al
    Which is the optimal threshold for defining functional lung in single-photon emission computed tomography lung perfusion imaging of lung cancer patients?
    Nucl Med Commun. 2018;39:103-109.
    PubMed     Abstract available


  483. HEDON C, Huet F, Ben Bouallegue F, Vernhet H, et al
    Area at risk can be assessed by iodine-123-meta-iodobenzylguanidine single-photon emission computed tomography after myocardial infarction: a prospective study.
    Nucl Med Commun. 2018;39:118-124.
    PubMed     Abstract available


    January 2018
  484. BIBBO G, Sigalas V, Kirkwood I
    A review of paediatric administered radiopharmaceutical activities to determine compliance with prescription guidelines.
    Nucl Med Commun. 2018 Jan 30. doi: 10.1097/MNM.0000000000000800.
    PubMed     Abstract available


  485. HAROON A, Afaq A, Nuthakki S, Freeman A, et al
    Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with 68Ga-PSMA, radiolabelled choline and 68Ga-DOTATATE.
    Nucl Med Commun. 2018 Jan 30. doi: 10.1097/MNM.0000000000000797.
    PubMed     Abstract available


  486. BRAGHIROLI MI, Mota JM, Duarte PS, Morita TO, et al
    Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer.
    Nucl Med Commun. 2018 Jan 29. doi: 10.1097/MNM.0000000000000810.
    PubMed     Abstract available


  487. EVANGELISTA L, Cuppari L, Guttilla A, Gardi M, et al
    Oligometastatic recurrent prostate cancer detects by fluorine-18-choline positron emission tomography/computed tomography in patients with prostate-specific antigen levels of up to 5 ng/ml.
    Nucl Med Commun. 2018 Jan 29. doi: 10.1097/MNM.0000000000000808.
    PubMed     Abstract available


  488. MITTAL BR, Sood A, Shukla J, Vatsa R, et al
    99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes.
    Nucl Med Commun. 2018 Jan 29. doi: 10.1097/MNM.0000000000000802.
    PubMed     Abstract available


  489. CAYIR D, Araz M, Yalcindag A, Cakal E, et al
    The relationship between semiquantitative parameters derived from technetium-99m metoxyisobutylisonitrile dual-phase parathyroid single-photon emission computed tomography images and disease severity in primary hyperparathyroidism.
    Nucl Med Commun. 2018 Jan 22. doi: 10.1097/MNM.0000000000000803.
    PubMed     Abstract available


  490. LEI J, Zhao X, Xu B, Duan Z, et al
    Global scientific productivity in the field of PET: a 10-year survey of research activities.
    Nucl Med Commun. 2018 Jan 19. doi: 10.1097/MNM.0000000000000805.
    PubMed     Abstract available


  491. OSBORNE DR, Acuff SN, Neveu ML, Syed M, et al
    Feasibility assessment of yttrium-90 liver radioembolization imaging using amplitude-based gated PET/CT.
    Nucl Med Commun. 2018 Jan 18. doi: 10.1097/MNM.0000000000000794.
    PubMed     Abstract available


  492. BROOS WAM, van der Zant FM, Wondergem M, Knol RJJ, et al
    Accuracy of 18F-NaF PET/CT in bone metastasis detection and its effect on patient management in patients with breast carcinoma.
    Nucl Med Commun. 2018 Jan 18. doi: 10.1097/MNM.0000000000000807.
    PubMed     Abstract available


  493. WOJCIUK G, Kruszewski M
    [DTPA-(PABn)-Leu5]-des-acyl ghrelin(1-5) as a new carrier of radionuclides and potential precursor of radiopharmaceuticals.
    Nucl Med Commun. 2018 Jan 8. doi: 10.1097/MNM.0000000000000790.
    PubMed     Abstract available


  494. HALL DO, Hooper CE, Searle J, Darby M, et al
    18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma.
    Nucl Med Commun. 2018 Jan 3. doi: 10.1097/MNM.0000000000000789.
    PubMed     Abstract available


  495. WU X, Gu H, Gao Y, Li B, et al
    Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
    Nucl Med Commun. 2018;39:22-27.
    PubMed     Abstract available


    December 2017
  496. LENGANA T, van de Wiele C, Lawal I, Maes A, et al
    68Ga-PSMA-HBED-CC PET/CT imaging in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study.
    Nucl Med Commun. 2017 Dec 18. doi: 10.1097/MNM.0000000000000791.
    PubMed     Abstract available


  497. MHLANGA JC, Chirindel A, Lodge MA, Wahl RL, et al
    Quantitative PET/CT in clinical practice: assessing the agreement of PET tumor indices using different clinical reading platforms.
    Nucl Med Commun. 2017 Dec 8. doi: 10.1097/MNM.0000000000000786.
    PubMed     Abstract available


  498. DAVIDSON T, Komisar O, Korach J, Felder S, et al
    Physiologic uptake of 18F-FDG in transposed ovaries may mimic metastasis on 18F-FDG PET/CT imaging.
    Nucl Med Commun. 2017 Dec 5. doi: 10.1097/MNM.0000000000000785.
    PubMed     Abstract available


    November 2017
  499. ZHOU Z, Liu X, Hu K, Zhang F, et al
    The clinical value of PET and PET/CT in the diagnosis and management of suspected cervical cancer recurrence.
    Nucl Med Commun. 2017 Nov 20. doi: 10.1097/MNM.0000000000000775.
    PubMed     Abstract available


  500. RADHAKRISHNAN RK, Mittal BR, Basher RK, Prakash G, et al
    Post-therapy lesions in patients with non-Hodgkin's lymphoma characterized by 18F-FDG PET/CT-guided biopsy using automated robotic biopsy arm.
    Nucl Med Commun. 2017 Nov 20. doi: 10.1097/MNM.0000000000000780.
    PubMed     Abstract available


  501. WEBB HR, Latifi HR, Griffeth LK
    Utility of whole-body (head-to-toe) PET/CT in the evaluation of melanoma and sarcoma patients.
    Nucl Med Commun. 2017 Nov 17. doi: 10.1097/MNM.0000000000000778.
    PubMed     Abstract available


  502. JIANG M, Chen P, Ruan X, Xu W, et al
    Interim 18F-FDG PET/CT and BCL2 for predicting the prognosis of patients with diffuse large B-cell lymphoma in the rituximab era.
    Nucl Med Commun. 2017 Nov 17. doi: 10.1097/MNM.0000000000000784.
    PubMed     Abstract available


  503. EGE AKTAS G, Tastekin E, Sarikaya A
    Assessment of biological and clinical aggressiveness of invasive ductal breast cancer using baseline 18F-FDG PET/CT-derived volumetric parameters.
    Nucl Med Commun. 2017 Nov 10. doi: 10.1097/MNM.0000000000000779.
    PubMed     Abstract available


  504. YANO K, Kondo K, Nanashima A, Fujii Y, et al
    Preoperative maximal removal rate of technetium-99m-galactosyl-human serum albumin of the remnant liver is associated with postoperative tumor relapse in hepatitis C virus-related hepatocellular carcinoma.
    Nucl Med Commun. 2017 Nov 2. doi: 10.1097/MNM.0000000000000773.
    PubMed     Abstract available


  505. RAZAVI S, Ziebarth B, Klein R, Zeng W, et al
    Dual time-point quantitative SPECT-CT parathyroid imaging using a single computed tomography: feasibility and operator variability.
    Nucl Med Commun. 2017 Nov 2. doi: 10.1097/MNM.0000000000000761.
    PubMed     Abstract available


  506. VALLOT D, Caselles O, Chaltiel L, Fernandez A, et al
    A clinical evaluation of the impact of the Bayesian penalized likelihood reconstruction algorithm on PET FDG metrics.
    Nucl Med Commun. 2017;38:979-984.
    PubMed     Abstract available


    October 2017
  507. VALLOT D, Caselles O, Chaltiel L, Fernandez A, et al
    A clinical evaluation of the impact of the Bayesian penalized likelihood reconstruction algorithm on PET FDG metrics.
    Nucl Med Commun. 2017 Oct 18. doi: 10.1097/MNM.0000000000000729.
    PubMed     Abstract available


  508. GOENSE L, Heethuis SE, van Rossum PSN, Voncken FEM, et al
    Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.
    Nucl Med Commun. 2017 Oct 11. doi: 10.1097/MNM.0000000000000771.
    PubMed     Abstract available


  509. NGUYEN DL, de Labriolle-Vaylet C, Durand E, Fernandez PX, et al
    Reproducibility of differential renal function measurement using technetium-99m-ethylenedicysteine dynamic renal scintigraphy: a French prospective multicentre study.
    Nucl Med Commun. 2017 Oct 3. doi: 10.1097/MNM.0000000000000769.
    PubMed     Abstract available


  510. BAILLY P, Bouzerar R, Shields T, Meyer ME, et al
    Benefits of respiratory-gated 18F-FDG PET acquisition in lung disease.
    Nucl Med Commun. 2017 Oct 3. doi: 10.1097/MNM.0000000000000772.
    PubMed     Abstract available


  511. PARK HL, Yoo IR, O JH, Kim H, et al
    Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI.
    Nucl Med Commun. 2017 Oct 3. doi: 10.1097/MNM.0000000000000768.
    PubMed     Abstract available


  512. WOODS AM, Bolster AA, Han S, Poon FW, et al
    Dual-isotope subtraction SPECT-CT in parathyroid localization.
    Nucl Med Commun. 2017 Oct 3. doi: 10.1097/MNM.0000000000000765.
    PubMed     Abstract available


  513. KIM K, Kim SJ, Song SH, Kim IJ, et al
    Factors associated with diffusely increased renal uptake of Tc-99m diphosphono-propanedicarboxylic acid on bone scintigraphy in patients with end-stage renal disease.
    Nucl Med Commun. 2017 Oct 3. doi: 10.1097/MNM.0000000000000767.
    PubMed     Abstract available



  514. Brown adipose tissue detected by PET/CT imaging is associated with less central obesity: Erratum.
    Nucl Med Commun. 2017;38:883.
    PubMed    


  515. LOU J, Wen G, Dong K, Zhang Y, et al
    Early monitoring of osteoporosis treatment response by technetium-99m-methylene diphosphonate bone scan.
    Nucl Med Commun. 2017;38:854-857.
    PubMed     Abstract available


    September 2017
  516. TULSYAN S, Das CJ, Tripathi M, Seth A, et al
    Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer.
    Nucl Med Commun. 2017 Sep 27. doi: 10.1097/MNM.0000000000000749.
    PubMed     Abstract available


  517. WU Q, Luo W, Zhao Y, Xu F, et al
    The utility of 18F-FDG PET/CT for the diagnosis of adrenal metastasis in lung cancer: a PRISMA-compliant meta-analysis.
    Nucl Med Commun. 2017 Sep 25. doi: 10.1097/MNM.0000000000000757.
    PubMed     Abstract available


  518. USMANI S, Marafi F, Esmail A, Ahmed N, et al
    A proof-of-concept study analyzing the clinical utility of fluorine-18-sodium fluoride PET-CT in skeletal staging of oncology patients with end-stage renal disease on dialysis.
    Nucl Med Commun. 2017 Sep 25. doi: 10.1097/MNM.0000000000000759.
    PubMed     Abstract available


  519. MEYRICK DP, Asokendaran M, Skelly LA, Lenzo NP, et al
    The role of 68Ga-PSMA-I&T PET/CT in the pretreatment staging of primary prostate cancer.
    Nucl Med Commun. 2017 Sep 15. doi: 10.1097/MNM.0000000000000738.
    PubMed     Abstract available


  520. PURANDARE NC, Puranik A, Shah S, Agrawal A, et al
    Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation?
    Nucl Med Commun. 2017 Sep 15. doi: 10.1097/MNM.0000000000000753.
    PubMed     Abstract available


  521. MARTINEZ-AMADOR N, Jimenez-Bonilla J, Martinez-Rodriguez I, De Arcocha-Torres M, et al
    Value of the visual and semiquantitative analysis of carbon-11-methionine PET/CT in brain tumors' recurrence versus post-therapeutic changes.
    Nucl Med Commun. 2017 Sep 12. doi: 10.1097/MNM.0000000000000754.
    PubMed     Abstract available


  522. KHAZAEE M, Kamali-Asl A, Geramifar P, Rahmim A, et al
    Low-dose 90Y PET/CT imaging optimized for lesion detectability and quantitative accuracy: a phantom study to assess the feasibility of pretherapy imaging to plan the therapeutic dose.
    Nucl Med Commun. 2017 Sep 11. doi: 10.1097/MNM.0000000000000742.
    PubMed     Abstract available


  523. PANDEY AK, Bisht CS, Sharma PD, ArunRaj ST, et al
    Identification of optimal mask size parameter for noise filtering in 99mTc-methylene diphosphonate bone scintigraphy images.
    Nucl Med Commun. 2017 Sep 6. doi: 10.1097/MNM.0000000000000745.
    PubMed     Abstract available


  524. THOMAS BA, Molton JS, Leek F, Pang Y, et al
    A comparison of 18F-FDG PET/MR with PET/CT in pulmonary tuberculosis.
    Nucl Med Commun. 2017 Sep 6. doi: 10.1097/MNM.0000000000000743.
    PubMed     Abstract available


  525. PLOUZNIKOFF N, Arsenault F
    Clinical relevance of 18F-FDG PET/CT lower-limb imaging in patients with malignant cutaneous melanoma.
    Nucl Med Commun. 2017 Sep 6. doi: 10.1097/MNM.0000000000000747.
    PubMed     Abstract available


    August 2017
  526. SHARIFPOUR R, Ghafarian P, Rahmim A, Ay MR, et al
    Quantification and reduction of respiratory induced artifacts in positron emission tomography/computed tomography using the time-of-flight technique.
    Nucl Med Commun. 2017 Aug 31. doi: 10.1097/MNM.0000000000000732.
    PubMed     Abstract available


  527. USLU-BESLI L, Kabasakal L, Sager S, Cicik E, et al
    Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation.
    Nucl Med Commun. 2017 Aug 31. doi: 10.1097/MNM.0000000000000737.
    PubMed     Abstract available


  528. JIANG C, Liu J, Li L, Kosik RO, et al
    Predictive approaches for post-therapy PET/CT in patients with extranodal natural killer/T-cell lymphoma: a retrospective study.
    Nucl Med Commun. 2017 Aug 29. doi: 10.1097/MNM.0000000000000731.
    PubMed     Abstract available


  529. SHARMA A, Mohan A, Bhalla AS, Vishnubhatla S, et al
    Role of various semiquantitative parameters of 18F-FDG PET/CT studies for interim treatment response evaluation in non-small-cell lung cancer.
    Nucl Med Commun. 2017 Aug 16. doi: 10.1097/MNM.0000000000000723.
    PubMed     Abstract available


  530. MORRIS M, Saboury B, Chen W, Siegel EL, et al
    Finding the sweet spot for metformin in 18F-FDG-PET.
    Nucl Med Commun. 2017 Aug 10. doi: 10.1097/MNM.0000000000000728.
    PubMed     Abstract available


  531. SARIKAYA I, Elgazzar AH, Sarikaya A, Alfeeli M, et al
    Normal bone and soft tissue distribution of fluorine-18-sodium fluoride and artifacts on 18F-NaF PET/CT bone scan: a pictorial review.
    Nucl Med Commun. 2017 Aug 3. doi: 10.1097/MNM.0000000000000720.
    PubMed     Abstract available


  532. HUIZING ED, van Dijk JD, van Dalen JA, Timmer JR, et al
    Minimizing rubidium-82 tracer activity for relative PET myocardial perfusion imaging.
    Nucl Med Commun. 2017;38:708-714.
    PubMed     Abstract available


  533. AL-MOHAMMAD A, Norton MY, Welch AE, Walton S, et al
    Characterization of viability, scarring and hibernation of the myocardium supplied by epicardial coronary arteries with low flow grades.
    Nucl Med Commun. 2017;38:657-665.
    PubMed     Abstract available


  534. HUAN W, Aiqin W, Jianping L, Qianqian X, et al
    Radiosynthesis and in-vivo evaluation of [125I]IBT: a single-photon emission computed tomography radiotracer for alpha7-nicotinic acetylcholine receptor imaging.
    Nucl Med Commun. 2017;38:683-693.
    PubMed     Abstract available


  535. PAREKH A, Graham R, Redman S
    Ventilation/perfusion single-photon emission computed tomography: a service evaluation.
    Nucl Med Commun. 2017;38:672-675.
    PubMed     Abstract available


    July 2017
  536. LANZA E, Donadon M, Felisaz P, Mimmo A, et al
    Refining the management of patients with hepatocellular carcinoma integrating 11C-choline PET/CT scan into the multidisciplinary team discussion.
    Nucl Med Commun. 2017 Jul 18. doi: 10.1097/MNM.0000000000000719.
    PubMed     Abstract available


  537. MARAFI F, Esmail A, Rasheed R, Alkandari F, et al
    Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
    Nucl Med Commun. 2017 Jul 18. doi: 10.1097/MNM.0000000000000706.
    PubMed     Abstract available


  538. GORIN MA, Mareshdeh W, Ross AE, Allaf ME, et al
    Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsi.
    Nucl Med Commun. 2017 Jul 12. doi: 10.1097/MNM.0000000000000716.
    PubMed     Abstract available


  539. MOREAU A, Giraudet AL, Kryza D, Borson-Chazot F, et al
    Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.
    Nucl Med Commun. 2017 Jul 12. doi: 10.1097/MNM.0000000000000708.
    PubMed     Abstract available


  540. DEMIRKAYA O, AlQahtani M, Alsugair A, Aras O, et al
    Analysis of metastatic involvement in bone using anatomical and functional information from 18F-FDG PET/CT.
    Nucl Med Commun. 2017 Jul 12. doi: 10.1097/MNM.0000000000000714.
    PubMed     Abstract available


  541. LEE JW, Lee EY, Hong SY, Yoo ID, et al
    The clinical significance of technetium-99m methylene diphosphonate bone scintigraphy findings in patients with rhabdomyolysis.
    Nucl Med Commun. 2017 Jul 7. doi: 10.1097/MNM.0000000000000709.
    PubMed     Abstract available


  542. CIFTCI E, Turgut B, Cakmakcilar A, Erturk SA, et al
    Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
    Nucl Med Commun. 2017 Jul 7. doi: 10.1097/MNM.0000000000000712.
    PubMed     Abstract available


  543. DONG H, Zhang Z, Guo Y, Zhang H, et al
    The application of technetium-99m-red blood cell scintigraphy in the diagnosis of orbital cavernous hemangioma.
    Nucl Med Commun. 2017 Jul 7. doi: 10.1097/MNM.0000000000000711.
    PubMed     Abstract available


  544. SHEIKHBAHAEI S, Ahn SJ, Young B, Taghipour M, et al
    Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancer.
    Nucl Med Commun. 2017 Jul 3. doi: 10.1097/MNM.0000000000000707.
    PubMed     Abstract available


  545. MATESAN MM, Bowen SR, Chapman TR, Miyaoka RS, et al
    Assessment of functional liver reserve: old and new in 99mTc-sulfur colloid scintigraphy.
    Nucl Med Commun. 2017;38:577-586.
    PubMed     Abstract available


  546. HANNEY MB, Hillel PG, Scott AD, Lorenz E, et al
    Half-body single photon emission computed tomography with resolution recovery for the evaluation of metastatic bone disease: implementation into routine clinical service.
    Nucl Med Commun. 2017;38:623-628.
    PubMed     Abstract available


  547. TAYLOR JC, Murray AW, Hall DO, Barnfield MC, et al
    UK audit of quantitative thyroid uptake imaging.
    Nucl Med Commun. 2017;38:608-616.
    PubMed     Abstract available


    June 2017
  548. MALLORIE A, Goldring J, Patel A, Lim E, et al
    Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumour SUVmax/2 has the highest specificity.
    Nucl Med Commun. 2017 Jun 27. doi: 10.1097/MNM.0000000000000703.
    PubMed     Abstract available


  549. YANO K, Nanashima A, Fujii Y, Hiyoshi M, et al
    Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin is correlated with liver functional parameters, but did not predict postoperative morbidity.
    Nucl Med Commun. 2017 Jun 22. doi: 10.1097/MNM.0000000000000702.
    PubMed     Abstract available


  550. GUO R, Wang J, Zhang M, Zhang M, et al
    Value of 99mTc-MIBI SPECT/CT parathyroid imaging and ultrasonography for concomitant thyroid carcinoma.
    Nucl Med Commun. 2017 Jun 13. doi: 10.1097/MNM.0000000000000692.
    PubMed     Abstract available


  551. LAFFON E, Milpied N, Marthan R
    Measurement uncertainty of lesion and reference mediastinum standardized uptake value in lung cancer.
    Nucl Med Commun. 2017;38:509-514.
    PubMed     Abstract available


  552. NORIEGA-ALVAREZ E, Martinez Pimienta GA, Benitez Segura AM, Bajen Lazaro MT, et al
    Utility of 8 h and time decay-corrected acquisition scintigraphy with in-vitro labeled white blood cells for the diagnosis of osteoarticular infection.
    Nucl Med Commun. 2017;38:500-508.
    PubMed     Abstract available


  553. HUA Q, Zhu X, Zhang L, Zhao Y, et al
    Initial experience with real-time hybrid single-photon emission computed tomography/computed tomography-guided percutaneous transthoracic needle biopsy.
    Nucl Med Commun. 2017;38:556-560.
    PubMed     Abstract available


  554. LEE GH, Lee JH
    Clinical significance of incidental prostatic fluorine-18-fluorodeoxyglucose uptake in the diagnosis of infectious prostatitis in adult males.
    Nucl Med Commun. 2017;38:523-528.
    PubMed     Abstract available


    May 2017
  555. DUBREUIL J, Salles G, Bozzetto J, Tordo J, et al
    Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review.
    Nucl Med Commun. 2017 May 31. doi: 10.1097/MNM.0000000000000697.
    PubMed     Abstract available


  556. GOLUBIC AT, Pasini Nemir E, Zuvic M, Mutvar A, et al
    The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values.
    Nucl Med Commun. 2017 May 30. doi: 10.1097/MNM.0000000000000696.
    PubMed     Abstract available


  557. HAS SIMSEK D, Sanli Y, Kulle CB, Karanlik H, et al
    Correlation of 18F-FDG PET/CT with pathological features and survival in primary breast cancer.
    Nucl Med Commun. 2017 May 26. doi: 10.1097/MNM.0000000000000694.
    PubMed     Abstract available


  558. GREEN AL, Bagci U, Hussein S, Kelly PV, et al
    Brown adipose tissue detected by PET/CT imaging is associated with less central obesity.
    Nucl Med Commun. 2017 May 15. doi: 10.1097/MNM.0000000000000691.
    PubMed     Abstract available


  559. SHINJYO M, Naniwa M, Kubo N, Nishimura Y, et al
    Optimal injected dose ratio of a very rapid 1-day protocol of myocardial perfusion imaging with cadmium-zinc-telluride single-photon emission tomography: simulation and phantom study.
    Nucl Med Commun. 2017 May 9. doi: 10.1097/MNM.0000000000000689.
    PubMed     Abstract available


  560. MA JT, Han CB, Zheng JH, Sun HZ, et al
    Hybrid PET/MRI-based delineation of gross tumor volume in head and neck cancer and tumor parameter analysis.
    Nucl Med Commun. 2017 May 9. doi: 10.1097/MNM.0000000000000687.
    PubMed     Abstract available


  561. SCHUITEVOERDER D, Grinlington L, Stevens J, Nance R, et al
    Nonvisualized sentinel lymph nodes on lymphoscintigraphy in melanoma: predictive factors and surgical outcomes.
    Nucl Med Commun. 2017;38:383-387.
    PubMed     Abstract available


  562. HAN J, Liu H, Liu C, Jin H, et al
    Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.
    Nucl Med Commun. 2017;38:372-382.
    PubMed     Abstract available


  563. HIPPELAINEN ET, Tenhunen MJ, Maenpaa HO, Heikkonen JJ, et al
    Dosimetry software Hermes Internal Radiation Dosimetry: from quantitative image reconstruction to voxel-level absorbed dose distribution.
    Nucl Med Commun. 2017;38:357-365.
    PubMed     Abstract available


    April 2017
  564. IBALL GR, Bebbington NA, Burniston M, Edyvean S, et al
    A national survey of computed tomography doses in hybrid PET-CT and SPECT-CT examinations in the UK.
    Nucl Med Commun. 2017 Apr 27. doi: 10.1097/MNM.0000000000000672.
    PubMed     Abstract available


  565. ARMSTRONG IS, Thomson KE, Rowley LM, McGowan DR, et al
    Harmonizing standardized uptake value recovery between two PET/CT systems from different manufacturers when using resolution modelling and time-of-flight.
    Nucl Med Commun. 2017 Apr 25. doi: 10.1097/MNM.0000000000000682.
    PubMed     Abstract available


  566. GIZEWSKA A, Witkowska-Patena E, Osiecki S, Mazurek A, et al
    Utility of single-photon emission tomography/computed tomography for sentinel lymph node localization in breast cancer patients.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000676.
    PubMed     Abstract available


  567. YANG CC, Yang BH, Tu CY, Wu TH, et al
    Low-dose computed tomography scans with automatic exposure control for patients of different ages undergoing cardiac PET/CT and SPECT/CT.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000679.
    PubMed     Abstract available


  568. PRIAMO J, Adamopoulos D, Rager O, Frei A, et al
    Downstream indication to revascularization following hybrid cardiac PET/MRI: preliminary results.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000680.
    PubMed     Abstract available


  569. MARUOKA Y, Nagao M, Baba S, Isoda T, et al
    Three-dimensional fractal analysis of 99mTc-MAA SPECT images in chronic thromboembolic pulmonary hypertension for evaluation of response to balloon pulmonary angioplasty: association with pulmonary arterial pressure.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000673.
    PubMed     Abstract available


  570. EVANGELISTA L, Cervino AR, Michieletto S, Saibene T, et al
    Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients.
    Nucl Med Commun. 2017 Apr 13. doi: 10.1097/MNM.0000000000000671.
    PubMed     Abstract available


  571. UYAMA N, Otsuka H, Shinya T, Otomi Y, et al
    The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Nucl Med Commun. 2017 Apr 13. doi: 10.1097/MNM.0000000000000674.
    PubMed     Abstract available


  572. VENNART NJ, Bird N, Buscombe J, Cheow HK, et al
    Optimization of PET/CT image quality using the GE 'Sharp IR' point-spread function reconstruction algorithm.
    Nucl Med Commun. 2017 Apr 7. doi: 10.1097/MNM.0000000000000669.
    PubMed     Abstract available


  573. CHISM CB, Ravizzini GC, Macapinlac HA, Pan T, et al
    Quantitative comparison between regularized time-of-flight and OSEM PET reconstructions for small 18F-FDG-avid lesions.
    Nucl Med Commun. 2017 Apr 5. doi: 10.1097/MNM.0000000000000670.
    PubMed     Abstract available


  574. HAROON A, Syed R, Endozo R, Allie R, et al
    Spectrum of metastatic and nonmetastatic skeletal findings with dual-phase 18F-FECH PET/CT in patients with biochemical relapse of prostate cancer.
    Nucl Med Commun. 2017 Apr 4. doi: 10.1097/MNM.0000000000000665.
    PubMed     Abstract available


  575. TAYWADE SK, Ramaiah VL, Basavaraja H, Venkatasubramaniam PR, et al
    Prevalence of ECG changes during adenosine stress and its association with perfusion defect on myocardial perfusion scintigraphy.
    Nucl Med Commun. 2017;38:291-298.
    PubMed     Abstract available


  576. RAO H, Gaur N, Tipre D
    Assessment of diabetic neuropathy with emission tomography and magnetic resonance spectroscopy.
    Nucl Med Commun. 2017;38:275-284.
    PubMed     Abstract available


    September 2016

  577. News and Views-September 2016.
    Nucl Med Commun. 2016;37:999.
    PubMed    


  578. JIANG Z, Liu Y, Xin C, Zhou Y, et al
    Normal stress-only myocardial single photon emission computed tomography predicts good outcome in patients with coronary artery stenoses between 40 and 70.
    Nucl Med Commun. 2016;37:899-903.
    PubMed     Abstract available


  579. DAVIDSON T, Komissar O, Goshen E, Shalmon B, et al
    Focal fluorine-18 fluorodeoxyglucose-avid parotid findings in patients with lung cancer: prevalence and characteristics.
    Nucl Med Commun. 2016;37:969-74.
    PubMed     Abstract available


  580. BAHK YW, Chung YA, Lee UY, Park SI, et al
    Gamma correction 99mTc-hydroxymethylene diphosphonate pinhole bone scan diagnosis and histopathological verification of trabecular contusion in young rats.
    Nucl Med Commun. 2016;37:988-91.
    PubMed     Abstract available


  581. KANGASMAA TS, Constable C, Hippelainen E, Sohlberg AO, et al
    Multicenter evaluation of single-photon emission computed tomography quantification with third-party reconstruction software.
    Nucl Med Commun. 2016;37:983-7.
    PubMed     Abstract available


  582. SURIYANTO, Ng EY, Say XJ, Ng CE, et al
    Quantitative means for differentiating renal obstruction by analysing renography by compartmental modelling of renal fluid flow rate.
    Nucl Med Commun. 2016;37:904-10.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: